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Reversible S-palmitoylation confers spatiotemporal control of protein function by 
modulating protein stability, trafficking and activity  as well as protein-protein and 
membrane-protein associations. While it is evident that palmitoylation is regulated in 
vivo, mechanisms that mediate cellular stimuli-driven changes of the lipid modification 
are not understood. Furthermore, the requirement for substrate specificity among the 
highly redundant palmitoyl acyltransferases (PATs) remains unresolved. 
To study the regulation of PATs and palmitoylomes, I developed bioorthogonal 
chemical strategies for improved analysis of dynamic palmitoylation in mammalian cells. 
I showed that alkyne-functionalized fatty acids, in conjunction with azido-fluorophores, 
provide the most sensitive detection of acylated proteins following CuI-catalyzed azide-
alkyne cycloaddition. Linkage-specific hydrolysis, mutagenesis and inhibitor studies 
reveal that these alkynyl-fatty acids are incorporated into proteins by endogenous fatty-
acylation machinery via native linkages at specific amino acid residues. In addition, 
shorter and longer chain fatty acids label myristoylated and palmitoylated proteins 
respectively. Since myristoylation is co-translational and constitutive, I employed both 
palmitoylation and myristoylation chemical reporters with orthogonal fluorophores to 
simultaneously  monitor palmitate and protein turnover. Dual pulse-chase analysis of Lck, 
a tyrosine kinase required for T-cell signaling, revealed accelerated palmitate cycling 
upon T-cell activation. Pharmacological perturbation of Lck palmitate turnover suggests 
yet uncharacterized serine hydrolases contribute to dynamic palmitoylation in cells. 
These significant improvements allow rapid and robust biochemical analysis of 
palmitoylated proteins without overexpression, facilitating the functional characterization 
of cellular factors and drugs that modulate protein palmitoylation.
Taking advantage of the sensitive bioorthogonal detection of protein 
palmitoylation and the simple PAT network in the fission yeast Schizosaccharomyces 
pombe, I provided evidence for regulation of PATs and palmitoylomes in vivo at 
physiological enzyme and substrate concentrations. I showed that the Erf2-Erf4 PAT 
modulates sexual differentiation, and that upregulation of its expression is required to 
establish the meiotic palmitoylome. Importantly, I demonstrated that changes in Erf2-
Erf4 levels within the physiological range control PAT specificity and result in the 
differential palmitoylation of its substrates in vegetative and meiotic cells. Underscoring 
the biological significance of controlling PAT levels, Erf2-Erf4 overproduction in 
proliferating cells alters the palmitoylome and the subcellular distribution of Rho3, a 
major meiotic target, stimulating sexual differentiation in the absence of normal 
physiological cues. From this study, I conclude that PAT substrate specificity  depends on 
enzyme levels and propose the rheostatic control of PAT activity as a mechanism by 
which cells shape stimuli-induced palmitoylomes. Future questions stemming from this 
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Post-translational modifications are important for protein function
Post-translational modifications of proteins (PTMs) are important for building functional 
complexity of proteomes in living organisms. To date, more than 200 PTMs involving the 
covalent attachment of metabolites and other proteins, both static and dynamic, have been 
identified. Together, they increase the diversity of functional groups beyond those in the 
side chains of the 20-22 proteinogenic amino acids, enabling new chemistry, new 
recognition patterns for binding partners as well as control of enzyme activity, protein 
stability  and location (Fig. 1.1b). The function and regulation of some of these 
modifications such as phosphorylation have been extensively  studied and characterized. 
In contrast, our understanding of modifications such as S-palmitoylation, the focus of this 
thesis, is limited.
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Figure 1.1 | Post-translational modifications (PTMs) are  important for protein function. a, 
Different  covalent  modifications of proteins, depicted by red circles, generate proteome 
complexity and diversify protein function. b, Examples of PTMs (red) of indicated amino acid 
side chains. Major forms of protein lipidation are indicated in box.
Protein S-palmitoylation
Lipid modifications, myristoylation, palmitoylation and prenylation (Fig. 1.1b, box), 
increase protein hydrophobicity, primarily functioning as lipid anchors to stabilize 
protein-membrane interactions and in some cases directly regulate protein activity as well 
as protein-protein interactions. These distinct lipid modifications differ not only in 
chemical linkage, chain length and degree of saturation of the lipids, but also in the 
associated enzymes, which recognize discrete protein substrates. S-Palmitoylation, also 
known as S-acylation, is the only  reversible lipid modification - the palmitate turns over 
faster than the protein itself1, 2. Palmitoylation takes place on the thiol side chains of 
cysteine residues post-translationally via thioester linkages (Fig. 1.2). Although it 
typically involves attachment of a saturated 16-carbon palmitate group to proteins, 
2
incorporation of longer fatty acids with different degrees of unsaturation have been 
reported3-5. Some proteins, such as the secreted Sonic hedgehog morphogen6-9, are 
irreversibly palmitoylated through the formation of an N-terminal amide bond (N-
palmitoylation) but in this thesis, palmitoylation refers to S-palmitoylation. To date, there 
is no unique consensus site, making it challenging to accurately predict palmitoylated 
proteins and modification sites.
Figure 1.2 | Protein  S-palmitoylation is  a reversible  modification. Palmitate is installed on the 
thiol side chain of a cysteine residue through the formation of a thioester linkage (red). 
Palmitoylation and depalmitoylation are mediated by a family of palmitoyl acyltransferases 
(PATs) and thioesterases, respectively. No reliable consensus palmitoylation sequence has been 
identified. 
 Nonetheless, recent technical advancements enabled comprehensive global 
characterization of palmitoyl-proteomes (palmitoylomes) in yeast and mammalian cells, 
which reveal that ~1-2% of proteomes are modified10-18. These studies greatly expanded 
the known complement of palmitoylated proteins and indicated important roles for this 
lipid modification as a major cellular regulator in diverse biological processes such as 
cell death and proliferation, immune signaling and neuronal function (Table 1.1). In this 
chapter, I will discuss how palmitoylation impacts protein function (Part 1) and how this 
modification is regulated in cells (Part 2). 
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Table 1.1 | Representative palmitoylated proteins.







*RHOB Adamson et al.
167
*Kang et al.11
*Brain-specific CDC42 isoform 2 *Kang et al. 11















GAP43 (neuromodulin) Skene et al.183
*eNOS Liu et al.
218
*Ho et al.40
Huntingtin Yanai et al.50
CaMK1G Takemoto-Kimura et al.184
GAD65 Christgau et al.
Stathmin 2 (SCG10) Grenninglog et al.217
Channels, receptors, transporters other transmembrane proteins
G protein-coupled 
receptors
Rhodopsin OʼBrien et al.185




GluR1, GluR2 Hayashi et al.
215
*Kang et al.11
Large conductance (BK) K+ channel Tian et al.88
Cell adhesion molecules
Integrin α6 Yang et al.186
CD9 (tetraspannin 29) Yang et al.214
Cell death signaling FAS Chakrabandhu et al.187
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Table 1.1 continued |
Protein family Substrate Reference
Adaptors and scaffolds
*PSD95 (Post Synaptiic Density protein 95) Topinka & Bredt213
*El-Hussini et al.39
GRIP1, GRIP2 DeSouza et al.212
LAT (Linker for Activation of T-cells) Zhang et al.31
Proteins involved in protein sorting and vesicle trafficking
SNAREs SNAP25B Hess et al.211
*Syntaxin1, Syntaxin 6 Martin et al.
13
*Kang et al.11
Synaptobrevin 2 Martin et al.
13
Kang et al.11
Synaptotagmins *Synaptotagmin 1 Heindel et al.
188
*Kang et al.11
Others CSP Chamberlain & Burgiyne189
*CKAP4 (p63) Schweizer et al.
210
*Mundy & Warren56
IFITM3 Yount et al.16
*Changes in palmitoylation states have been associated with different cellular or physiological 
states.
Part 1: Palmitoylation-mediated regulation of protein function
Protein targeting and trafficking
Palmitoylation primarily targets proteins to specific membrane compartments in the cell. 
The small GTPase Ras, an important molecular switch in diverse signaling networks 
governing cell death, proliferation, differentiation that is well-known for its role in cancer 
development19, provides an important paradigm for spatial control mediated by this lipid 
modification. Nras and Hras are two highly homologous isoforms, differing mainly in 
their hypervariable C-terminal regions, where Nras and Hras are both prenylated and 
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either mono- or dual- palmitoylated2, 20, 21 (Fig. 1.3a). These isoforms have distinct 
cellular distribution with Hras being more enriched at the plasma membrane relative to 
the Golgi22 (Fig. 1.3a). This is dependent on their palmitoylation states since localization 
of mono-palmitoylated Hras mutants more closely resemble Nras22 (Fig. 1.3b). Notably, a 
non-palmitoylated Hras mutant is randomly  distributed to all membranes (Fig. 1.3b, 
C181, 184S), indicating that prenylation alone is insufficient to target proteins to specific 
membranes22. In fact, it  is appreciated that other lipid modifications such as 
myristoylation and prenylation (Fig. 1.1b) act as weak membrane anchors while 
palmitoylation, although not usually  the primary membrane association signal, is a strong 
membrane anchor that specifies the membrane distribution of a protein23 (Fig. 1.3d, steps 
1-3). The reversibility  of palmitoylation is also crucial for its function. Microinjection of 
a semisynthetic Nras that is irreversibly-linked to palmitate results in non-specific 
distribution of the protein (Fig. 1.3c), demonstrating that correct localization of Nras 
requires both palmitoylation and depalmitoylation22 (Fig. 1.3d). Cycles of palmitoylation 
and depalmitoylation govern protein-membrane associations, allowing key signaling 
proteins to shuttle and relocalize between intracellular membrane compartments22, 24, 25. 
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Figure 1.3 | Dynamic palmitoylation regulates localization of Ras isoforms. a, Distinct 
cellular distribution of two YFP-tagged Ras isoforms, Nras and Hras, which are mono- and 
dually- palmitoylated, respectively. Both isoforms are also prenylated. b, Palmitoylation 
determines membrane-specific localization of Hras. Cellular distribution of YFP-tagged Hras 
palmitoylation mutants, C184S, C181S or C181, 184S. Box, overexposed area reveals 
endoplasmic reticulum (ER) and plasma membrane (PM) localization of the C181S Hras mutant. 
c, Cellular distribution of synthetically-derived Cy5-labeled Nras with either native thioester-
linked or a non-cleavable thioether-linked palmitate upon microinjection into cells. a-c, Adapted 
from Rocks et al.22. d, Model for how palmitoylation regulates Ras trafficking. Newly 
synthesized Ras is prenylated and reversibly binds ER and Golgi membranes and traffic between 
them via a soluble cytosolic intermediate (step 1). Palmitoylation by a palmitoyl acyltransferase 
(PAT) kinetically traps Ras onto membranes in the early secretory pathway (step 2) and enables 
trafficking to the PM (step 3). Palmitate turnover generates a transiently depalmitoylated pool of 
protein that  is returned to the Golgi and/or ER compartments by non-vesicular transport, where it 
again can interact with PATs at the Golgi and/or ER and reenter the secretory pathway (step 4). 
Adapted from Goodwin et al.24
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Spatial compartmentalization increases the complexity of signal outputs
By influencing their subcellular distribution, dynamic palmitoylation can have critical 
effects on the function and signaling outputs of proteins as epitomized by 
compartmentalized Ras signaling. Studies indicate that a Ras protein signals though 
distinct downstream effectors and pathways from a variety of membrane compartments22, 
26, addressing the conundrum of how a binary molecular switch like Ras, which cycles 
between GTP-bound active and GDP-bound inactive forms, can selectively control 
multiple pathways (Fig. 1.4). Unambiguously showed by Onken and colleagues using the 
single Ras protein in fission yeast27, 28 (Fig. 1.4b), compartmentalized Ras signaling also 
explains how the different Ras isoforms in mammals, though highly homologous and 
indistinguishable in most in vitro assays, perform non-overlapping biological functions19. 
In addition to maintaining the differential subcellular distribution of Hras and Nras 
isoforms, different de/repalmitoylation kinetics account for isoform-specific activation 
responses by regulating their partitioning between membrane compartments22, 24. It is 
clear that compartmentalized signaling increases the complexity of signaling outputs but 
it remains to be determined how palmitoylation, with its potential to impart rapid 
spatiotemporal control of protein function, affects distribution of signals across multiple 
platforms and influences the selectivity of signal outputs. 
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Figure 1.4 | Palmitoylation-modulated compartmentalized Ras signaling increases the 
complexity of signaling outputs in a, Mammals and b, fission yeast. Palmitoylated and non-
palmitoylated Ras proteins localize to different  membrane platforms, where they signal through 
different  effectors and pathways involved in important cellular processes/events as indicated. PM: 
plasma membrane. 
Membrane microdomains as signaling platforms
Palmitoylation is also important for controlling the lateral segregation of proteins into 
membrane microdomains such as lipid rafts, which are ordered assemblies of proteins 
and lipids enriched in sterols and sphingolipids29. Several lines of evidence from studies 
in immune cell signaling suggest that this lipid modification functions modulates raft 
association of proteins. First, palmitoylation of proteins such as non-receptor tyrosine 
kinases Lck and Fyn, adaptor LAT, as well as co-receptors CD4 and CD8 are critical for 
T-cell signaling. Disruption of palmitoylation results in loss of raft association by these 
proteins, which is concomitant with abrogation of T-cell signaling3, 30-35. Second, 
substitution of palmitate on Lck with a more hydrophilic oxygen-substituted palmitate 
analog that disrupts lipid packing also reduces raft association and weakens its signaling 
activity36. Third, although artificial targeting of chimeric Lck and LAT constructs to the 
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plasma membrane without raft association restored their function in T-cell signaling, their 
signaling properties are altered37, 38. Together, these observations strongly  indicate 
palmitoylation-mediated targeting to membrane microdomains can affect the function and 
signaling outputs of proteins.
 How does targeting to membrane microdomains affect protein activity? The 
concept of compartmentalized signaling described previously can be applied to laterally 
divided subdomains within the same membrane compartment. Palmitoylation partitions 
proteins to common membrane microdomains or raft environments that are miscible, 
facilitating particular protein-protein interactions (Fig. 1.5a). In contrast, interactions 
between proteins in two non-miscible environments are less favored (Fig. 1.5b). By 
changing the lateral distribution of proteins within the same membrane compartment, 
palmitoylation can rapidly and reversibly modulate protein-protein interactions. 
Figure 1.5 |  Model  for regulation  of protein-protein interactions by palmitoylation-mediated 
microdomain association. a, Palmitoylation targets proteins to common membrane 
microdomains or raft environments that  are miscible, thereby facilitating dynamic protein-protein 
interactions. b, Interactions between proteins in two non-miscible environments are less favored.
10
 Interestingly, many peripheral and transmembrane proteins required for signaling 
at neuronal and immune synapses are palmitoylated31, 39-41, suggesting a tantalizing 
possibility of lipid rafts as signaling platforms where reversible palmitoylation can 
rapidly regulate signaling strength by coordinating various lipid-protein and protein-
protein associations42.
Beyond membrane targeting
Besides inter- and intra- membrane targeting, palmitoylation controls protein activity  in 
diverse ways such as inducing protein conformational changes43, 44, modulating protein 
stability45-49 and aggregation50 as well as interacting with a variety of PTMs. Crosstalk 
between palmitoylation and other PTMs will be elaborated later in this chapter.
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Part 2: Regulation of protein palmitoylation
As reviewed in Part 1, palmitoylation controls various aspects of protein distribution and 
function. Given its versatility  and reversibility, palmitoylation is a potential major cellular 
regulator akin to phosphorylation. If this were true, one expects palmitoylation to be 
actively regulated and that this will have functional consequences on cellular physiology. 
This is best exemplified by  the neuronal scaffold PSD95. Receptor activity-regulated 
palmitate turnover of PSD95 modulates synaptic strength and plasticity  in post-synaptic 
neurons by mediating receptor clustering39, 51. Importantly, this effect is specific since 
palmitoylation of other neuronal proteins, GluR2 and GRIP1, is unaffected under the 
same conditions51. Besides neuronal activity, other extracellular signals have been shown 
to alter the palmitoylation state or rate of palmitate turnover in different cell types (Table 
1.1, *proteins). Accelerated depalmitoylation of G-protein subunits, G-protein coupled 
receptors and a non-tyrosine kinase Lck upon receptor stimulation suggest active 
regulation of de/re-palmitoylation52-55. Additionally, a broader level of control is 
suggested by  global changes in palmitoylomes that are associated with specific 
physiological states of the cell or organism11, 56. While it is clear that this lipid 
modification is regulated in vivo, the field is in its early days and little is known of how 
these changes in palmitoylation states occur and how they affect cellular function.
 Similar to how phosphorylation is regulated by protein kinases and phosphatases, 
it is conceivable that enzymes catalyzing the palmitoylation and depalmitoylation 
reactions are regulated. Here, I review the evidence for regulation of these enzymes and 
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the other mechanisms that modulate protein palmitoylation as well as what these mean in 
terms of cellular function.
Palmitoyl acyltransferases (PATs) 
A family of Asp-His-His-Cys-containing palmitoyl acyltransferases (DHHC-PATs) found 
in all eukaryotes examined is responsible for most protein palmitoylation events12. 
Discovered in Saccharomyces cerevisiae, AKR157 and ERF2-ERF458 are instrumental 
towards understanding the enzymology of protein palmitoylation. ERF2 requires an 
additional cofactor ERF4 for catalyzing palmitate transfer to its substrates58, as does its 
mammalian DHHC9 homolog59, while AKR1 exhibit  sufficient activity by itself like 
most other PATs. ERF2 and AKR1 are integral membrane proteins with 4 and 6 
transmembrane domains respectively, with the conserved DHHC domain that is required 
for catalytic activity facing the cytosol60 (Fig.1.6a). Demonstrated by two groups using 
ERF2-ERF4 and mammalian PATs, DHHC2 DHHC3 and DHHC9-GCP16, PATs catalyze 
palmitoylation via a two-step  ping-pong mechanism first involving autopalmitoylation of 
the enzyme followed by palmitoyl transfer to protein substrates61, 62. Although mutation 
of the conserved cysteine in the DHHC motif abrogates both autopalmitoylation and 
transfer57, 58, 61-63, there still lacks definitive evidence that it is the catalytic cysteine due to 
the current inability to isolate and identify the palmitoyl-enzyme intermediate. 
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Figure 1.6 | Structure  of PATs. a, PATs are integral membrane proteins with typically 4 or 6 
predicted transmembrane domains. The conserved DHHC motif required for catalytic activity is 
located on the cytoplasmic face. Adapted from Young et  al.64 b, Domain structures of 
representative human PATs. Besides a DHHC core domain, each DHHC protein has individual 
protein–protein-interacting domains such as a PDZ-binding motif, an SH3 domain and ankyrin 
repeats. Blue and green backgrounds show the DHHC2/15 and DHHC3/7 subfamilies, 
respectively. Adapted from Fukata et al.41
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PAT-substrate specificity
The multiple DHHC-containing PATs in an organism, ranging from a handful in 
unicellular fungi to more than twenty in metazoa, raise intriguing questions about 
substrate specificity and regulation.
 On one hand, most studies support the notion that specific PAT-substrate pairs are 
needed for palmitate transfer. A systematic screen of all 23 mammalian PATs by gain- and 
loss- of-function studies revealed that only a subset of PATs (DHHC2, 3 and 7) 
quantitatively increase palmitoylation of a model substrate PSD9565. Palmitoylome 
analysis of various PAT-deficient mutants in budding yeast provided clear evidence for 
PAT-substrate specificity with individual PATs showing a preference for substrates with 
common features12. For example, ERF2-ERF4 substrates tend to be heterolipidated (e.g. 
myristoylated or prenylated), SWF1 substrates tend to be transmembrane proteins and 
AKR1 preferentially modifies soluble hydrophilic proteins12. Evidence of specificity 
determinants on both substrates66 and enzymes67 further supports substrate specificity 
among members of the PAT family. Huang and co-workers demonstrated that transfer of 
the HIP14/DHHC17 ankyrin repeat domain to DHHC3 enabled it to modify huntingtin, a 
HIP14/DHHC17 substrate67, highlighting the importance and potential of domains 
outside the DHHC domain in regulating PAT-substrate specificity and function (Fig. 
1.6b).
 On the other hand, a recent study examining the kinetics of membrane association 
and partitioning of microinjected semisynthetic fluorescent lipopeptides suggested that 
protein palmitoylation was neither stereoselective nor sequence-specific and that 
substrate specificity was not required for dynamic palmitoylation in cells68. This is 
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supported by Hou and colleagues, who showed strong biochemical and functional overlap 
between the different PATs in budding yeast69. A potential concern for these studies is the 
use of non-physiological concentrations of substrates and/or enzymes, which may be 
accompanied by loss of PAT specificity. 
 Nonetheless, it is evident and consistent among the different studies that there is 
to a certain extent, biochemical and functional overlap between multiple PATs in 
organisms12, 65, 68, 69, which makes understanding their roles in regulating global protein 
palmitoylation and cellular physiology challenging.
Differential regulation of PATs
Physiological state-dependent changes in the palmitoylation of individual proteins and in 
palmitoylomes suggest mechanisms by which PATs “sense”  regulatory inputs and 
coordinate differential modification of its substrates. To date, there is little evidence for 
regulation of PATs and how it impacts protein palmitoylation as well as cellular function.
 Specific PATs were found to have different subcellular locations and tissue-
specific distribution70, 71, suggesting the possibility that PAT localization and expression 
levels may be important for cellular function. As the first documentation of differential 
PAT regulation, Noritake and colleagues showed in neurons that activity-sensitive 
DHHC2 translocation enhances PSD95 palmitoylation and synaptic receptor clustering51. 
Although how PAT localization is determined and altered in response to synaptic activity 
is unclear, such stimulus-specific compartmentalization of PAT function may be a general 
mechanism to regulate protein palmitoylation. Recent studies by the Chamberlain lab 
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identified sorting signals on several PATs that target these enzymes to defined membrane 
compartments as well as regulate PAT cycling between compartments72, 73.
 PATs may also be regulated by PTMs such as palmitoylation and ubiquitination18, 
74, 75. Interestingly, ubiquitination and subsequent proteasome-mediated degradation of 
DHHC5 were observed when cultured neural stem cells were induced to differentiate74. 
Nonetheless, it remains to be determined how induced PAT degradation affects substrate 
palmitoylation and impacts neuronal differentiation. From a bigger picture, are PATs 
modified by other PTMs and how do they regulate PAT function?
 Further supporting that PATs have distinct substrates and modulate specific 
physiological functions, misregulation and mutation of specific PATs in mammals are 
involved in different neurological and developmental defects as well as various cancers 
(Table 1.2). Given the importance of PAT-mediated palmitoylation in many biological 
systems, it  is important to elucidate mechanisms that control PAT activity  in 
physiologically relevant contexts.
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Table 1.2 | PATs involved in human diseases





Weaker huntingtin (HTT)–HIP14 interaction and 
reduced palmitoylation in presence of disease-








Phenotype in mice lacking HIP14 resembles mouse 
model of HD. Singaraja et al.
208
In vitro ZDHHC13/HIP14L Reduced HTT palmitoylation in vitro. Saleem et al.
191
Mouse HIP14, HIP14L HTT modulates HIP14 and HIP14L activity. Huang et al.
75
Alzheimerʼs In vitro ZDHHC12 DHHC12 is involved in amyloid protein precusor metabolism (including Aβ production). Mizumaru et al.
192
Schizophrenia
Human DHHC8 Associated with patients with schizophrenia. Liu et al.207
Mouse ZDHHC8 Pre-pulse inhibition deficit in female knockout mice. Mukai et al.193
Mouse ZDHHC8







Human DHHC9 Severe nonsyndromic XLMR, epileptic seizures, dysmorphic facial appearance. Raymond et al.
194
Human DHHC15 Moderate XLMR in males.Developmental delay. Mansouri et al.
205
Non-neurological developmental defects
Multiple defects Mouse ZDHHC13/HIP14L
Knockout mice have shortened life spans, global 
amyloidosis, and hair, skin, and bone abnormalities. Saleem et al.
191
Hair and skin 
defects Mouse ZDHHC21
Loss of ZDHHC21 function results in skin 





and metastasis Human DHHC2
Potential tumor suppressor genes for various 
cancers are mapped to chromosomal region 8p22 
that contains the DHHC2 gene
Oyama et al.203
Qin et al.196
Bladder cancer Human DHHC11
Increased copy number of chromosome region 




Table 1.2 continued | 
Disease Model PAT Observations Reference
Non-small lung 
cancer Human DHHC11
Increased copy number of chromosome region 





DHHC9 transcript is upregulated in the majority of 









DHHC20 overexpression induces cellular 
transformation.









HIP14 overexpression induces cellular 
transformation. Ducker et al.
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Depalmitoylating enzymes/ protein thioesterases
In contrast to the large PAT family, few protein thioesterases with depalmitoylating 
activity have been identified and they are relatively uncharacterized. Biochemical efforts 
to purify depalmitoylating enzymes have yielded lysosomal palmitoyl protein 
thioesterase 1 (PPT1) and cytosolic acyl protein thioesterase 1 (APT1), both of which can 
depalmitoylated proteins in vitro76-78. 
 PPT1, a lysosomal protein is responsible for degrading palmitoylated proteins, is 
thought to be topologically incompatible with depalmitoylating cytoplasmic proteins79. 
Nonetheless, recent studies show that PPT1 is also found in presynaptic compartments in 
neurons and that it may play a role in synaptic vesicle cycling80, 81.
 Consistent with its ability to depalmitoylate Hras and Gαi in vitro77, APT1 
overexpression promoted depalmitoylation of Gαs and eNOS in mammalian cultured 
cells82 and disruption of APT1 function in budding yeast resulted in decreased palmitate 
turnover on GPA1, the yeast Gα homolog78. Treatment of cells with an inhibitor 
19
(Palmostatin B) designed to target APT1, an α/β serine hydrolase with a canonical serine/
histidine/aspartate catalytic triad83, 84, increased steady state Ras palmitoylation and 
cellular redistribution of Ras proteins84. While this study provides the first evidence that 
Ras is a substrate of APT1 in cells, it is possible that this is due to off-target effects of 
Palmostatin B on other similar serine hydolases and protein thioesterases including PPT1 
and APT283, which has been shown to deacylate GAP43 in cells85. Recently, APT1 was 
implicated in neuronal morphogenesis when it was found to be a target of a neuronal 
enriched microRNA, miR13886. Down-regulation of APT1 function was associated with 
increased association of Gα13 with the membrane and higher dendritic spine volume86. It 
would be interesting to see if other palmitoylated proteins in neurons41 are actually  APT1 
substrates and if they contribute to neuron morphogenesis and activity.
 Given the limited number of APT1 substrates that  are validated in vivo compared 
to diverse proteins that undergo regulated palmitate turnover14, it  remains to be 
determined if PPT1, APT1 and their related isoforms are the main deacylating enzymes 
or if there are potentially more enzymes to be uncovered. As with discovery of the PATs, 
identification of the thioesterases would allow perturbation of the palmitoylation/
depalmitoylation cycle and yield insights into the regulation and physiological function 
of dynamic palmitoylation.
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Accessibility of modification sites
Protein palmitoylation can be modulated by  mechanisms that influence the accessibility 
of substrates or modification sites to the palmitoylation or depalmitoylation enzymatic 
machinery. An example is the promotion of Ras depalmitoylation by  prolyl isomerase 
FKBP1287 (Fig. 1.7). Ahearn and co-workers showed that  FKBP12 binds to Hras in a 
palmitoylation-dependent manner and regulates its trafficking by  promoting 
depalmitoylation through cis-trans isomerization of a peptidyl-prolyl bond close to 
palmitoylated cysteines. Inhibition of FKBP12 prolyl isomerase activity by a variety of 
chemical inhibitors such as FK506, rapamycin and cycloheximide increases Hras steady 
state palmitoylation87. While only proteins with proline residues close to palmitoylation 
sites can potentially be regulated by this mechanism, it is conceivable that any changes in 
protein conformation that influence the accessibility of the modification sites, can affect 
the palmitoylation/depalmitoylation cycle.
Figure 1.7 | Controlling depalmitoylation by altering the 
accessibility of modification sites. FKBP12 binds Hras and 
promotes its depalmitoylation by cis-trans isomerization of a 




Substrate accessibility can also be modulated by crosstalk between different PTMs. 
Negatively-charged phosphate groups may prevent palmitoylation of an adjacent cysteine 
by preventing association with membranes, where PATs are localized (Fig 1.8a, 1). In a 
reciprocal manner, one would also expect palmitoylation to prevent phosphorylation by 
blocking access of kinases to nearby serine, threonine or tyrosine residues88-91 (Fig. 1.8a, 
2). Nitrosylation competes with the PATs for modification sites (Fig. 1.8b). PSD95 is 
physiologically  nitrosylated at the same cysteines that are palmitoylated and 
physiologically produced nitric oxide (NO) inhibits PSD95 palmitoylation and synaptic 
clustering in vivo, demonstrating direct  competition between these cysteine 
modifications40. Since NO is an established modulator of many biological processes 
including synaptic transmission92, dynamic reciprocity  between nitrosylation and 
palmitoylation may explain how synaptic activity regulates PSD95 palmitoylation as well 
as synaptic clustering and activity. Further examination of palmitoylated substrates for 
competing cysteine modifications (e.g. nitrosylation and sulfhydration) would help 
determine if this is a general mechanism for regulating protein palmitoylation.
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Figure 1.8 |  Interplay between palmitoylation and other PTMs. a, Proximity-dependent 
reciprocal regulation between phosphorylation and palmitoylation. (1) Negatively-charged 
phosphate group (P, yellow circle) prevents palmitoylation of an adjacent cysteine (Cys, red) by 
blocking membrane interaction. (2) Palmitoylation-mediated membrane association prevents 
access of protein kinases to an adjacent  phosphorylation site. b, Direct  competition for 
modification sites. (1) Nitrosylation (NO (nitric oxide, orange circle) may prevent  palmitoylation 
by direct  competition for cysteine residues (Cys, red) and vice versa. Nitrosylation may deplete 
the pool of depalmitoylated substrates available for repalmitoylation. Other cysteine 
modifications may have similar regulatory effects. Note that these examples are not mutually 
exclusive, nor do they illustrate the full range of effects that these PTMs have on each other.
While it  is clear that  protein palmitoylation is important for protein function and 
is regulated in vivo, the identity and physiological roles of mechanisms that regulate 
palmitoylation is limited. In this thesis, I describe the development of chemical tools that 
improves the detection and identification of dynamically  palmitoylated proteins, present 
the fission yeast Schizosaccharomyces pombe as a new model organism useful for PAT 




BIOORTHOGONAL DETECTION OF PROTEIN FATTY-ACYLATION 
IN MAMMALIAN CELLS
Introduction
Many cellular proteins are covalently modified by lipids, the addition and removal of 
which regulates diverse biological processes ranging from cellular growth and 
differentiation to lymphocyte activation and synaptic transmission. In eukaryotes, fatty 
acids, isoprenoids and glycosylphosphatidylinositols constitute the three prevalent forms 
of lipid modifications. In this chapter, I will be focusing on the two major forms of 
protein fatty-acylation, S-palmitoylation and N-myristoylation, which are characterized 
by the chain length of the acyl group attached to proteins (Table 2.1).
 S-Palmitoylation, also known as S-acylation, is the only characterized reversible 
lipid modification that takes place on the thiol side chains of cysteine residues post-
translationally  via a thioester linkage1. Although it typically involves attachment of a 
saturated 16-carbon palmitate to proteins, incorporation of longer fatty  acids with 
different degrees of unsaturation have been reported3-5. Unlike N-myristoylation, there is 
no unique consensus palmitoylation motif, making it  difficult to accurately predict 
palmitoylated proteins and modification sites. The functional role of palmitoylation in 
physiology and disease is covered in Chapter 1.
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Myristoylation is the irreversible attachment of a saturated 14-carbon myristate to N-
terminal glycine resides of proteins that is mediated by  N-myristoyltransferases 
(NMTs)93. Although myristoylation predominantly occurs during protein translation, it 
can occur post-translationally  on N-terminal glycine residues revealed by proteolytic 
cleavage of protein substrates94. Studies indicate that myristoylation promotes weak 
transient protein-membrane associations that would be further stabilized by a second 
signal such as palmitoylation23. In addition to being an essential modification95, 96, protein 
myristoylation has been implicated in infectious and neurological diseases as well as 
various cancers97. This is exemplified by  different classes of myristoyl switch proteins, of 
which conformation changes modulates accessibility  of the myristate group and thus their 
interactions with the membranes and other proteins98-102. 
 Given the critical role of fatty-acylation in modulating protein behavior, the 
ability  to detect, characterize and probe their involvement in cellular function is 
important. Traditional autoradiographic detection of radioactive (3H or 14C) fatty  acids 
that are metabolically  incorporated into proteins, while effective, requires exposure times 
spanning days or weeks. Radioactive iodinated (I125)-fatty  acids improves detection time 
but are hazardous and not readily available103. These limitations are circumvented by two 
different approaches of visualizing fatty-acylated proteins using streptavidin 
immunoblotting (Fig. 2.1). First, the acyl-biotin exchange protocol (ABE) involves the 
covalent at tachment of biot in-HPDP (N-[6-(biot inamido)hexyl]-3 ′-(2′-
pyridyldithio)propionamide) to free thiols on proteins that are liberated by hydroxylamine 
cleavage of thioester-linked palmitate groups104 (Fig. 2.1a). The combination of ABE 
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with mass spectrometry-based proteomics using multidimensional protein identification 
technology to yeast and neurons has revealed many new S-palmitoylated proteins in 
eukaryotes11, 12. However, this approach is limited to S-acylated proteins since the amide 
linkages of myristoylated proteins are resistant to hydroxylamine1. Furthermore, it is 
limited to the analysis of steady state palmitoylation. Developed by my research advisor, 
Dr. Howard Hang, the second approach allows visualization of both myristoylated and 
palmitoylated proteins. This bipartite labeling approach involving metabolic 
incorporation of azide-functionalized fatty acids followed by selective addition of 
phosphine-biotin probes via Staudinger ligation105 (Fig. 2.1b). While these 
complementary  approaches offer rapid and convenient detection of fatty-acylation, 
immunoblotting methods are not ideal for analyzing quantitative changes in protein fatty-
acylation necessary for investigating dynamics or regulatory mechanisms.
Figure 2.1 | Non-radioactive immunoblot detection of fatty-acylated proteins in eukaryotes. 
a, Acyl-biotin exchange. b, Metabolic labeling and Staudinger ligation.
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 I initiated this thesis by developing bioorthogonal methods for improved 
fluorescent detection of endogenously expressed fatty-acylated proteins in mammalian 
cells. Through comparative analysis of substrates representing different classes of fatty-
acylated proteins, I demonstrated the fatty acid chemical reporters are indeed taken up by 
cells and specifically  incorporated into proteins at canonical modification sites via native 
linkages. Furthermore, I showed that alkynyl-fatty  acid chemical reporters, in 
combination with in-gel fluorescence scanning, provide superior and quantitative 
detection of fatty-acylated proteins. Finally, Dr. Lun Tsou and I developed a tandem 
labeling and detection method to simultaneously monitor dynamic palmitoylation and 
protein turnover. The sensitivity  and efficiency of this approach should facilitate the 




Bioorthogonal detection of protein fatty-acylation in mammalian cells
Advances in bioorthogonal labeling methods employing copper(I)-catalyzed Huisgen [3 
+ 2] cycloaddition (CuAAC) or “click chemistry” reaction between alkyl azides and 
alkynes (Fig. 2.2b) offered an opportunity to improve the analysis of fatty-acylated 
proteins using chemical reporters. To that end, a fellow graduate student in the lab, 
Guillaume Charron, synthesized a series of azido- and alkynyl-fatty acids of different 
lengths (Fig. 2.2c) as potential chemical reporters as well as a panel of biotinylated (alk-
biotin, az-biotin) and fluorescent (alk-rho, az-rho) detection tags (Fig. 2.2d). Together 
with another graduate student  in the lab, John Wilson, we optimized bioorthogonal 
reaction conditions and showed that fluorescence detection of fatty-acylated proteins in 
whole cell lysates using alkynyl chemical reporters is more sensitive compared to 
radioactive and immunoblot detection methods described previously. 
 Analysis of protein fatty-acylation at the proteome level, while important, is 
biased towards highly abundant proteins in cells where the dynamic range of protein 
concentrations can span more than seven orders of magnitude106-108. By immunopurifying 
proteins of interest prior to CuAAC (Fig. 2.2a), I was able to detect chemical reporter 
incorporation into substrates representing different classes of fatty-acylated proteins: S-
palmitoylated Linker for Activation of T-cells (LAT)31, N-myristoylated and S-
palmitoylated Lck109, 110, as well as S-palmitoylated and S-prenylated Ras2, 20, 21 (Fig. 2.3). 
Fluorescence at the expected molecular weight of each substrate was only observed in 
samples that were metabolically labeled with the fatty acid chemical reporters (Fig 2.3b).
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Figure 2.2 | Analysis of protein fatty-acylation with chemical  reporters. a, Metabolic labeling 
of mammalian cells with chemical reporters and bioorthogonal labeling of proteins. b, Copper(I)-
catalyzed Huisgen [3 + 2] cycloaddition or “click chemistry” enables selective covalent 
attachment of detection tags to azido or alkynyl substrates. c, Fatty acid chemical reporters. d, 
Clickable detection tags. 
 As a first indication of the specificity of these fatty-acylation chemical reporters, 
no fluorescent signal was observed for p53, a non-acylated protein (Fig. 2.3b). This 
approach allows analysis of less abundant proteins and focused studies of individual 
proteins of interest, detection of which may not be readily apparent at the lysate level.
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Figure 2.3 | Robust fluorescent detection of fatty-acylated proteins. a, Schematic 
representation of lipidation sites for LAT (S-palmitoyl-Cys26, S-palmitoyl-Cys29), Lck (N-
myristoyl-Gly2, S-palmitoyl-Cys3, S-palmitoyl-Cys5) and H-Ras (S-palmitoyl-Cys181, S-
palmitoyl-Cys184, S-prenyl-Cys186), which represent  different  classes of fatty-acylated proteins. 
b, In-gel fluorescent detection of fatty-acylated proteins in lysates and of immunopurified 
proteins. p53, non-fatty-acylated protein. 
Fatty acid chemical reporters exhibit chain-length dependent labeling of N-
myristoylated and S-palmitoylated proteins
The ability to assess chemical reporter incorporation into individual proteins allows 
evaluation of different detection methods and specificity  of the chemical reporters. For 
these studies, Jurkat cells were metabolically labeled with azido- or alkynyl- fatty acids 
and their incorporation into LAT, Lck and Ras was detected using biotinylated or 
fluorescent detection tags. Fluorescent detection of immunopurified fatty-acylated 
proteins was markedly improved compared to detection by streptavidin blotting (Fig. 
2.4). Longer palmititc acid analogues (az-15, alk-16), which should be incorporated into 
all three S-acylated proteins, was nearly undetectable by streptavidin blotting (Fig. 2.4a) 
but robustly visualized by in gel fluorescence scanning (Fig. 2.4b). Shorter myristic acid 
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analogues (az-12, alk-12), which should label N-myristoylated proteins, are preferentially 
incorporated into Lck and to a lesser extent into LAT and Ras by fluorescence (Fig. 2.4b). 
This is not unexpected since S-acylation involves a heterogenous composition of fatty 
acids3-5.
 It is unclear why  detection of S-acylated proteins is more efficient with myristic 
acid compared to palmitic acid analogues by streptavidin blotting. It is possible that az-12 
or alk-12 labeled proteins transfer more efficiently from the gel to the membrane and are 
thus better detected by  streptavidin blot than the more hydrophobic az-15 or alk-16 
proteins. Variability  in protein transfer efficiency would be circumvented by direct in-gel 
fluorescent detection, which is the more consistent and reproducible detection method 
over the multiple repeats of this experiment (data not shown). Notably, the orientation of 
alkyne and azide functional groups also influence overall detection sensitivity, with the 
alkynyl-chemical probes giving higher signal-to-noise compared to their azide 
counterparts (Fig. 2.4b). This is consistent with studies using alkyne- or azide-
functionalized chemical probes111, 112. Overall, these experiments demonstrate that 
alkynyl-fatty acid chemical reporters, in combination with in-gel fluorescence detection, 
afford optimal detection of fatty-acylated proteins.
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Figure 2.4 | Alkynyl chemical reporters, in conjunction with in-gel fluorescence  scanning, 
affords optimal detection of fatty-acylated proteins. a, Comparative analysis of click 
chemistry orientation with LAT, Lck and Ras by streptavidin blotting and b, in gel-fluorescence 
scanning. *non-specific bands.
Fatty acid chemical reporters are incorporated into proteins at canonical modification 
sites via native linkages
In-gel hydroxylamine treatment of alkynyl-fatty acid-labeled Lck and LAT reduced the 
fluorescent signal derived from alk-16 on both proteins, but  did not alter the alk-12 
labeling of Lck (Fig. 2.5a). We also analyzed the specificity of our fatty acid chemical 
reporters with wild-type and mutant constructs of p59 Fyn113, a well-characterized N-
myristoylated and S-palmitoylated Src-family  kinase, by  overexpression in HeLa cells, 
metabolic labeling and immunoprecipitation (Fig. 2.5b, c). Fatty-acylation of wild-type 
Fyn is readily detected with alk-12 and alk-16 labeling, whereas the N-myristoylation 
G2A mutant exhibited significantly reduced alk-12 labeling and was undetectable with 
alk-16. The dual S-palmitoylation-deficient C3,6S mutant was efficiently  labeled with 
alk-12 and not with alk-16. These results are quantitatively identical to previously 
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described experiments using radiolabeled fatty acids, which also demonstrated residual 
labeling of G2A mutant Fyn with a 125I-myristic acid analogue and no labeling with 125I-
palmitic acid analogue3, 113. These experiments also support the model that N-
myristoylation precedes S-palmitoylation and highlight the possibility of fatty-acylation 
at N-terminal alanine residues. Collectively, our experiments with cell lysates and 
specific proteins demonstrate that  alk-12 labels N-myristoylated and S-acylated proteins, 
whereas longer-chain fatty acid chemical reporters such as alk-16 preferentially  target S-
acylated proteins.
Figure 2.5 | Fatty acid chemical  reporters exhibit linkage  and residue specific labeling of 
proteins. a, Hydroxylamine sensitivity of alkynyl-fatty acid Lck and LAT labeling in Jurkat cells. 
Shown are fluorescence scans of the same gel before and after hydroxylamine treatment. b, 
Schematic representation of lipidation sites of Fyn (N-myristoyl-Gly2, S-palmitoyl-Cys3, S-
palmitoyl-Cys6). c, Comparative analysis of the acylation states of wild type (WT), G2A mutant 
and C3,6S mutant Fyn in HeLa cells.
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Tandem fluorescence imaging of two different protein modifications 
An opportunity to visualize two distinct  chemical reporters in the same sample arose 
when Dr. Tsou developed a set of clickable fluorescent detection tags (az/alk-Cyfur) with 
near-IR photophysical properties that are orthogonal to the rhodamine detection tags114. 
The following studies were done in close collaboration with Dr. Tsou.
Figure 2.6 | Tandem orthogonal  imaging of two different protein modifications. a, Following 
metabolic labeling with two chemical reporters, immunopurification and sequential click 
chemistry reactions with orthogonal detection tags allow simultaneous visualization of two 
protein modifications. b, Fatty acid chemical reporters and clickable fluorescent detection tags. c, 
Tandem detection of az-12 and alk-16 on Lck using alk-Cyfur and az-rho respectively. Western 
blot is probed for Lck. Lower panels are fluorescence scans of the same gel after hydroxylamine 
treatment. *, non-specific bands.
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To explore the simultaneous metabolic labeling and detection of two distinct chemical 
reporters, we focused on Lck, an N-myristoylated and S-palmitoylated non-receptor 
tyrosine kinase required for T-cell activation110, 115, 116 and exploited the chain-length 
specificity between different fatty  acid chemical reporters (Fig. 2.5a). Lck was 
immunopurified from Jurkat T-cells that were metabolically  labeled with either one or 
both of the myristate (az-12/alk-12) and palmitate (az-15/alk-16) analogs and subjected to 
sequential on-bead CuAAC reactions with az-rho and alk-Cyfur (Fig. 2.6a, b). Washes 
after the first reaction removes excess reagents that  could quench the second CuAAC 
reaction. Orthogonal visualization of the two chemical reporters was achieved with in-gel 
fluorescence scanning. At 532 nm excitation/580 nm emission, az-rho signal was 
observed for samples labeled with alkynyl-fatty  acid reporters (alk-12 and alk-16), while 
alk-Cyfur fluorescence at 633 nm excitation/670 nm emission was only detected in with 
samples exposed to azido-fatty acid reporters (az-12 and az-15) (Fig. 2.6c, upper panel). 
Consistent with the differential biochemical reactivity of thioester and amide linkages1, 
in-gel hydroxylamine treatment selectively  diminished fluorescence associated with 
thioester-linked palmitate analogs (az-15/alk-16) compared to amide-linked myristate 
analogs (az-12/alk-12) (Fig. 2.6c, lower panel). These results demonstrate that both sets 
of fatty  acid chemical reporters are specifically incorporated by N-myristoylation and S-
palmitoylation cellular machinery  through native chemical linkages. For the first time, we 
show sensitive fluorescent detection of dually-modified proteins using two distinct 
chemical reporters in parallel. Our tandem imaging method is complementary to copper-
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mediated and copper-free click chemistry  strategies that have been used for time-resolved 
imaging of single biosynthetic pathways117-120.
Measuring palmitate turnover on proteins using tandem fluorescence imaging
Next, we determined if we can measure palmitate cycling on proteins by  using the 
tandem imaging method to orthogonally monitor palmitoylation and protein synthesis52. 
Traditionally, palmitoylation turnover rates are obtained from pulse chase studies using 
3H-palmitate and 35S-methionine, with limitations associated with autoradiographic 
detection. To monitor palmitate cycling with fluorescence, we envisioned a pulse-chase 
experiment employing distinct chemical reporters with orthogonal readouts (Fig. 2.7a) – 
one to monitor dynamic palmitoylation and the other to function as an internal control for 
protein turnover. Since myristoylation is primarily a co-translational and constitutive 
modification1, a myristate analog should function as an efficient chemical reporter for the 
amount and loading of myristoylated proteins.
 We first evaluated whether incorporation of alk-16 into S-acylated proteins is 
reversible in cells. Lck was immunopurified from Jurkat cells that were pulse-labeled 
with az-12 and alk-16 followed by a 10-fold excess palmitate chase for different lengths 
of time (Fig. 2.7a). Compared to the relatively  constant signal of az-12 labeling of Lck, 
the fluorescent signal from alk-16 labeling decayed over time (Fig. 2.7b-d). No decrease 
of az-12 signal was observed with excess myristate as the chase additive over 6 hours 
(Fig. 2.8a), demonstrating that az-12 is an effective chemical reporter of constitutive N-
myristoylation and protein loading. If alk-16 is efficiently  recognized by cellular 
37
thioesterases, we expect the calculated palmitate half-life on Lck using our method to 
agree with that of a previously reported pulse-chase study using 3H-palmitate and 35S-
methionine109.
Figure 2.7 | Measuring palmitate  turnover on Lck using the tandem imaging method. a, 
Scheme of pulse-chase experiment. b, Pulse-Chase analysis of Lck. c, Data from multiple chase 
experiments (n=10). Data points from the same chase times, after normalizing alk-16/az-12 
signals, were compiled and displayed as average values ± s.e.m. d, Plots of relative signals for 
alk-16, az-12 fluorescence and anti-Lck blot intensities in the pulse-chase experiments. 
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Figure 2.8 |  Pulse-Chase  controls. a, In-gel fluorescence scanning in the alk-Cyfur channel 
shows no significant  turnover of az-12 on Lck upon chasing in the presence of excess myristate. 
b, The range of in-gel fluorescence intensities is linear compared to the amount of labeled 
substrate.
After confirming our fluorescence measurements are in the linear range (Fig. 
2.8b) and normalizing alk-16 to az-12 fluorescent signals, our calculated palmitate half-
life on Lck is ~50 minutes (Fig. 2.7c), which is comparable to that reported by Paige et. 
al. under similar experimental conditions109. Parallel analysis of another fatty-acylated 
kinase, Fyn110, 113, from the same lysates confirmed dual and specific labeling with the 
fatty acid reporters. The calculated palmitate turnover rate of Fyn is longer than Lck (Fig. 
2.9) and is consistent with the reported estimate of 1.5-2 hours121. These results 
demonstrate that the fatty  acid reporters and our tandem imaging method can be used to 
efficiently and accurately evaluate S-palmitoylation turnover on endogenously expressed 
proteins.
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Figure 2.9 | Pulse-Chase analysis  of Fyn. Data 
from a single pulse-chase experiment after 
normalizing alk-16/az-12 signals relative to that  of 
Lck.
Pevandate stimulation accelerates palmitate 
cycling on Lck 
Since receptor stimulation has been shown to 
increase palmitate turnover on various proteins including G-protein subunits and G-
protein coupled receptors53-55 and palmitoylation of Lck is crucial for T-cell activation38, 
122, 123, we asked whether T-cell activation affects palmitate cycling on Lck. We utilized 
pervandate (PV), a phosphatase inhibitor, since it has been shown to trigger an activation 
response similar to that  of TCR cross-linking124. Anti-phosphotyrosine immunoblots 
revealed substantial increase in protein phosphorylation upon PV-treatment (Fig. 2.10) 
and mobility  shift of Lck due to phosphorylation was also evident from anti-Lck blots 
and in-gel fluorescence scans (Fig. 2.10). 
Figure 2.10 | Pervanadate  stimulation of Jurkat T-cells increases protein  phosphorylation 
and alters Lck electrophoretic mobility. Analysis of phosphoproteins and Lck electrophoretic 
mobility in cells with or without pervanadate (PV) treatment. IPCC, immunoprecipitation-click 
chemistry.
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 PV treatment resulted in 2-3 fold increase in palmitate cycling on Lck (t1/2 ~15 
min) that was reproduced over several experiments (n = 7) (Fig. 2.11a), suggesting T-cell 
activation increases dynamic palmitoylation of Lck. The increase in alk-16 signal at later 
time points suggest recycling of alk-16 from cellular palmitoyl-CoA pools, which has 
been attributed to the discrepancy of palmitate half-life measurements obtained in pulse 
chase experiments and imaging studies. Palmitate half-life measurements based on pulse-
chase experiments are in the order of minutes or hours and are often inconsistent with 
rapid physiological responses that can occur on the seconds time scale. Photo-activation/
bleaching of palmitoylated proteins fused to fluorescent proteins estimate protein-bound 
palmitate to turnover in milliseconds or seconds22, 24, but these experiments only  measure 
the protein trafficking and do not the directly evaluate the lipidation state of the protein. 
 We initially performed 2 hr pulses of the az-12 and alk-16 chemical reporters to 
compare our results with reported 3H-palmitate pulse-chase studies109. To address the 
effects presented by recycling analog pools, we repeated the experiments with a shorter 
pulse time (30 min) prior to chasing with excess palmitate, which has been demonstrated 
to minimize recycling of substrates in pulse-chase studies125. The absolute fluorescence 
intensities observed for both az-12 and alk-16 were lower overall but they remained in 
the linear range. Consistent with less recycling of alk-16, shorter pulses yielded a faster 
palmitate half-life of ~30 min on Lck compared to the ~50 min obtained with longer 2 hr 
pulses and the normalized alk-16 signal plateaus at a lower level with shorter pulses (Fig. 
2.11b). The increase in palmitate turnover on Lck upon PV stimulation, however, persists 
with shorter pulse times with an estimated half-life of <5 min (Fig. 2.11c). Notably for 
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PV-treated cells, recovery  of alk-16 signal was observed even with a shorter pulse time, 
which can be attributed to the rapid recycling of alk-16. These results demonstrate our 
tandem imaging method can reveal rapid rates of palmitate cycling on proteins that are 
closer to values obtained using fluorescence microscopy and that T-cell stimulation with 
PV accelerates palmitate cycling on Lck.
Figure 2.11 | Pervanadate  stimulation  of Jurkat cells accelerates palmitate  cycling on Lck. a, 
Pulse-chase analysis of Lck in the presence of 0.1 mM pervanadate (PV). PV activation data from 
multiple pulse-chase experiments (n = 7). Data points from the same chase times, after 
normalizing alk-16/az-12 signals, were compiled and displayed as average values ± s.e.m. (Inset). 
b, Pulse-chase analysis of Lck upon PV treatment with a shorter pulse time. c, PV activation data 
averaged from two pulse-chase experiments with a shorter pulse time.
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Pharmacological perturbation of Lck palmitate cycling
Efforts to identify enzymes that can depalmitoylate proteins have revealed APT1 and 
PPT1 as candidates76-78. Since both enzymes are predicted to be serine hydrolases based 
on sequence homology  and structure studies, we investigated the effect of a broad-
spectrum serine hydrolase inhibitor on Lck depalmitoylation. Addition of methyl 
arachidonyl fluorophosphonate (MAFP) during the chase significantly retarded palmitate 
turnover on Lck (Fig. 2.12a), suggesting that serine hydrolases that are sensitive towards 
the reactive fluorophosphonate group of MAFP may contribute to Lck depalmitoylation 
in T-cells. In contrast, incubation with another broad-spectrum serine hydrolase inhibitor, 
phenylmethylsulfonyl fluoride (PMSF) had no apparent effect on the initial rate of 
palmitate removal (Fig. 2.12b). Structural studies suggest  that  the bulky aromatic group 
of PMSF sterically hinders its binding to the active site of lipid serine hydrolases such as 
PPT1126. Since PPT1 resides in lysosomal compartments that are not topologically 
compatible with cytosolic depalmitoylation reactions79, and APT1 depalmitoylation 
activity has only been demonstrated for limited substrates, enzyme(s) that deacylate Lck 
in cells remain unclear. Nonetheless, our results with mechanism-based inhibitors suggest 
that serine hydrolases with active sites similar to that of PPT1 may contribute to the 
observed thioesterase activity on Lck.
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Figure 2.12 | Pharmacological  perturbation of palmitate turnover on Lck. a, Pulse-chase 
analysis of Lck in the presence of chemical inhibitors. Data from multiple pulse-chase 
experiments (n = 2). Data points from the same chase times, after normalizing alk-16/az-12 
signals, were compiled and displayed as average values ± s.e.m. b, Pulse-chase analysis of Lck in 
the presence of PMSF. Data from pulse-chase experiment after normalizing alk-16/az-12 signals 
compared to chase conditions without chemical inhibitors.
 We also assessed the effect of 2-bromopalmitate (2BP), a PAT inhibitor commonly 
used to block protein palmitoylation30, 127. Interestingly, 2BP also decreased Lck 
depalmitoylation rate (Fig. 2.12a). The actual targets of 2BP in cells are unknown and 
several enzymes have been suggested to interact with 2BP128. It  is possible that 2BP, 
which harbors a reactive α -bromo-carboxyl functional group poised for nucleophilic 
attack, might also inhibit putative thioesterases. This raises concerns over the use of 2BP 
as a specific PAT inhibitor in cells and subsequent interpretation of the data. Collectively, 
these experiments demonstrate that such a dual detection method can be used to evaluate 
effects of chemical inhibitors on palmitate turnover. Development of more specific 
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inhibitors using this assay should facilitate discovery  and characterization of cellular 
factors that perturb palmitate turnover in cells.
Tandem imaging method can be generalized to include alternative chemical reporters
To evaluate the utility of our tandem imaging method beyond N-myristoylated proteins, 
we employed a general chemical reporter of protein synthesis. Azidohomoalanine (AHA, 
Fig. 2.13a), a well-described azide-bearing methionine surrogate shown to label newly 
synthesized proteins with no observed toxicity, is an attractive alternative129, 130. We used 
an HA-tagged H-RasG12V construct to analyze another class of S-palmitoylated proteins. 
In-gel fluorescence analysis of purified HA-tagged H-RasG12V expressed in HeLa cells 
that were metabolically labeled with alk-16 and AHA showed incorporation and 
orthogonal detection of both chemical reporters (Fig. 2.13b). 
 We then compared our tandem imaging pulse-chase data with reported radioactive 
studies of H-Ras variants131. Palmitate removal rates on oncogenic H-Ras isoforms have 
been experimentally shown to be ~1 hr131. Pulse-chase analysis revealed significantly 
faster chase kinetics for alk-16 than AHA, demonstrating dynamic S-palmitoylation and 
minimal turnover of H-RasG12V in the time points analyzed (Fig. 13b, c). The HA-tagged 
H-RasG12V construct appeared as doublets by Cyfur fluorescence and anti-HA western 
blot, but only the upper band is modified by alk-16 as observed with az-rho fluorescence, 
suggesting the slower migrating polypeptide is the lipid-modified isoform of H-RasG12V 
under these conditions. Average Cyfur fluorescence across both H-RasG12V isoforms was 
used for data normalization since both exhibited similar turnover rates. The palmitate 
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half-life on H-RasG12V was calculated to be ~50 min using our tandem imaging method 
over several experiments (n = 5) (Fig. 2.13b). This is consistent with the reported 
experimental palmitate turnover rates of other oncogenic H-Ras variants131. Based upon 
these experimental rates of palmitate cycling and GTP-binding measurements, the 
calculated palmitate half-life of fully  GTP-bound H-Ras is less than 10 min. The 
combined use of alk-16 with AHA should enable tandem fluorescence imaging of 
palmitate turnover on any S-acylated protein. Given its modularity and the wide spectrum 
of chemical reporters currently available132, this tandem imaging approach can be readily 
adapted to study other dynamic protein modifications.
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Figure 2.13 | Use of a general  protein synthesis chemical  reporter extends the tandem 
imaging method beyond N-myristoylated proteins. a, Amino acid chemical reporter for protein 
synthesis. b, Tandem detection of AHA and alk-16 on H-RasG12V in transfected HeLa cells. 
Western blot  is probed for the N-terminal HA epitope on H-RasG12V. c, Pulse-Chase analysis of 
H-RasG12V with AHA and alk-16. Data from multiple pulse-chase experiments (n  = 5). Data 
points from the same chase times, after normalizing alk-16/AHA signals, were compiled and 
displayed as average values ± s.e.m. d, Plots of relative signals for alk-16, AHA fluorescence and 




In this chapter, we have expanded the chemical toolbox for monitoring two major forms 
of protein fatty-acylation, N-myristoylation and S-palmitoylation, in mammalian cells. 
First, we established that fatty  acid chemical reporters, combined with improved 
bioorthogonal labeling conditions using CuAAC, enables specific and sensitive 
fluorescent detection of protein myristoylation and palmitoylation. We further extended 
this approach to enable tandem fluorescent detection of two protein modifications on 
proteins of interest and showed that this tandem imaging method can be used to 
efficiently monitor dynamic protein palmitoylation in cells.
 I have shown that sensitivity of the bioorthogonal labeling approach enables 
robust detection of endogenously  expressed fatty-acylated proteins within minutes after 
gel electrophoresis compared to days or weeks with radioactive analogues. Furthermore, 
in-gel fluorescence detection of fatty-acylated proteins circumvents the need to transfer 
proteins onto membranes for immunoblotting, which can be problematic for hydrophobic 
polypeptides, and thus provides a more direct  and quantitative means to detect protein 
fatty-acylation as well as measure palmitoylation dynamics in cells. These significant 
improvements in the detection of protein fatty-acylation offer new opportunities to 
interrogate the functions and regulatory mechanisms of protein fatty-acylation, in 
physiology and disease.
 There are caveats to the bioorthogonal labeling approach described in this chapter. 
First, it is likely that the fatty  acid chemical reporters might be metabolized into longer or 
shorter fatty acids such as acetate and be non-specifically installed onto proteins. While 
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this is not evident from the fact that the myristate and palmitate analogs preferentially 
label myristoylated and palmitoylated proteins respectively  and do not label p53, an 
acetylated protein (see Fig. 2.4), crosstalk between different  fatty acid pools in the cell 
can be reduced by  minimizing metabolic labeling times. Second, most likely  due to low 
incorporation efficiency of the AHA methionine surrogate into proteins cells, we were 
unable to detect AHA labeling of endogenous proteins and detection was possible only 
upon overexpression. As a result, non-myristoylated proteins like H-Ras will have to be 
overexpressed for us to measure palmitate turnover rates using the tandem detection 
method (see Fig. 2.13). This problem may be circumvented by the use of other chemical 
reporters for protein synthesis that are more efficiently incorporated into proteins.
 Application of our new tools revealed accelerated palmitate cycling of Lck upon 
T-cell stimulation, which raises several interesting questions. Studies demonstrate that 
Lck palmitoylation is required for proper T-cell activation by targeting Lck to the plasma 
membrane and maintaining its lipid raft association122, 123. Nonetheless, the physiological 
consequences of increased palmitate cycling rate during cellular stimulation is unclear. 
Live cell imaging studies suggest that Lck is dynamically recruited and distributed to the 
periphery of immunological synapses during cellular activation33. It is therefore possible 
that increased palmitate turnover upon T-cell activation serves to limit the proportion of 
raft-associated Lck and its access to downstream substrates or activators. Notably, 
accelerated palmitate turnover upon cellular stimulation have also been observed for 
other proteins including G-protein coupled receptors and neuronal scaffold PSD9539, 53-55, 
although how palmitate cycling on these proteins is modulated to be determined. For Lck, 
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it is possible that protein thioesterase activity is stimulated by downstream effects of TCR 
signaling such as release of calcium from intracellular stores in the ER. Alternatively, 
activated and phosphorylated Lck may assume a conformational change favorable 
towards spontaneous or enzymatic deacylation. Since protein thioesterases with 
depalmitoylating activity towards Lck are yet to be identified, mechanistic insights into 
the regulation of activity-induced palmitate turnover remain elusive. 
 To understand basic control mechanisms of protein palmitoylation, I was 
motivated to use the genetically  amendable fission yeast as a model because of its 
relatively simple palmitoylation machinery compared to metazoans. This transition to 
fission yeast will be further developed in the next chapter.
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Materials and Methods
Cell culture growth. Jurkat (human T-cell lymphoma) cells were propagated in RMPI 
1640 supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 µg/mL 
streptomycin in a humidified CO2 incubator at 37 ºC. Cell densities were maintained 
between 1 x 105 and 2 x 106 cells per mL. HeLa cells were cultured in DMEM, 
supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin with 100 µg/mL 
streptomycin and maintained in a humidified 37 °C incubator with 5% CO2. 
Transfection of wild type, G2A, C3,6S Fyn constructs and HA-tagged H-RasG12V. For 
transfection studies, HeLa cells were grown in a 10 cm culture plate supplemented with 
DMEM  containing 10% fetal bovine serum in a humidified CO2 incubator to 
approximately 90% confluence before transfection with 12-15 µ g of DNA using 
Lipofectamine 2000 (Invitrogen). The human Fyn constructs, wild-type and mutant Fyn 
cDNAs cloned into eukaryotic expression vector pCMV5 as well as N-terminal HA-
tagged H-RasG12V (PCNC10) construct were kindly  provided by Dr. Marilyn Resh 
(Memorial Sloan-Kettering Cancer Center). Cells were transfected about 16 hours prior 
to metabolic or pulse-chase labeling.
Metabolic labeling with fatty acid chemical reporters. Jurkat and HeLa cells were 
treated for 2 hours with 20 µM az-12, az-15, alk-12, alk-14 or alk-16 (50 mM DMSO 
stock solutions) using the corresponding media for the respective cell types in the 
humidified CO2 incubator at 37 ºC. The same volume of DMSO was used in the negative 
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control. Following metabolic labeling, cells were harvested, washed once with ice-cold 
PBS and pelleted at 1000 g for 5 min. Cells were directly lysed or flash frozen in liquid 
nitrogen and stored at -80 °C prior to lysis. No significant loss of signal was observed for 
frozen cell pellets.
Pulse-Chase labeling. Jurkat T-cells were labeled with 20 µM az-12 and 20 µM alk-16 in 
RMPI 1640 supplemented with 2% charcoal-filtered fetal bovine serum, 100 U/mL 
penicillin and 100 µg/mL streptomycin. For H-Ras studies, transfected HeLa cells were 
incubated with 1 mM  azidohomoalanine (AHA) and 20 µM  alk-16 in methonine-free 
DMEM  (Invitrogen) supplemented with 2% charcoal-filtered fetal bovine serum. The 
same volume of DMSO was used in the negative controls. After 2 hours or 30 minutes 
incubation, the labeled cells were chased with pre-warmed RMPI 1640 or DMEM 
containing 200 µM palmitate, 10% fetal bovine serum and/or 100 U/mL penicillin and 
100 µg/mL. 100 µM  2-bromopalmitate (2BP) (Fluka), 20 µM (MAFP) (Sigma) or 200 
µM phenylmethylsulfonyl fluoride (PMSF) were added to the chase medium to 
investigate the effects of small molecule inhibitors on palmitate turnover. To determine 
palmitate turnover upon T-cell activation, 100 mM  pervanadate, freshly prepared by 
dissolving sodium orthovanadate in 300 mM H2O2, was added to the chase medium for a 
final pervanadate concentration of 0.1 mM. Samples were taken at various time points 
during the chase, washed once with PBS and flash frozen in liquid nitrogen and stored at 
-80 ºC prior to lysis.
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Preparation of cell lysates. Frozen Jurkat or HeLa cell pellets were lysed in chilled Brij 
lysis buffer (1% Brij-97, 150 mM NaCl, 50 mM triethanolamine pH 7.4, 10× Roche 
EDTA-free protease inhibitor cocktail, 10 mM  PMSF) with vigorous vortexing (3 x 20 s), 
placing tubes on ice during intervals to avoid heating of samples. For analysis of protein 
phosphorylation after T-cell stimulation, 1:50 dilution of phosphatase inhibitor cocktail 2 
(Sigma) was included in the lysis buffer. Lysates were spun at 1,000 g for 5 minutes at 
room temperature to remove cellular debris. Typical lysate concentrations of 4-8 mg/ml 
were obtained, as quantified using the BCA assay (Pierce). 
Lysate CuAAC / click chemistry. Cell lysates (50 µg) in 44.5 µL RIPA lysis buffer were 
reacted with 5.5 µL freshly premixed click chemistry  reaction cocktail [azido- or alkynyl-
detection tag (100 µM, 5 mM  stock solution in DMSO), tris(2-carboxyethyl)phosphine 
hydrochloride (TCEP) (1 mM, 50 mM freshly  prepared stock solution in deionized 
water), tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA) (100 µM, 2 mM stock 
solution in 1:4 DMSO:t-butanol) and CuSO4·5H2O (1 mM, 50 mM  freshly  prepared stock 
solution in deionized water)] for a total reaction volume of 50 µL for 1 h at  room 
temperature. The reactions were terminated by the addition of ice-cold methanol (1 mL), 
placed at −80 °C overnight and centrifuged at  18000g for 10 min at 4 °C to precipitate 
proteins. The supernatant from the samples was discarded. The protein pellets were 
allowed to air-dry for 10 min, resuspended in 25 µL of SDS buffer (4% SDS, 50 mM 
triethanolamine pH 7.4, 150 mM NaCl). 8.7 µL 4×LDS sample buffer (Invitrogen) and 
1.3 µL 2-mercaptoethanol were then added and the samples were heated for 5 min at 95 
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°C; 20 µL of the sample was loaded per gel lane for separation by SDS-PAGE (4−20% 
Bio-Rad Criterion Tris-HCl gel).
Immunoprecipitation-CuAAC. LAT, Lck and Ras proteins were immunoprecipitated 
from 200 µg Jurkat cell lysate using the following antibodies at recommended 
concentrations: mouse anti-Lck (p56lck) monoclonal (Clone 3A5, Thermo Scientific), rat 
anti-v-H-ras (Ab-1) monoclonal (Y13-259 agarose conjugate, Calbiochem), and rabbit 
anti-LAT polyclonal (Upstate). A rabbit  anti-Fyn polyclonal (Upstate) was used to 
immunoprecipitate wild-type and mutant Fyn proteins HeLa cell lysates. Upon incubation 
at 4 °C for an hour with 25 µL of packed protein A-agarose beads (Roche) with an end-
over-end rotator (Barnstead/Thermolyne), the beads were washed three times with ice-
cold RIPA lysis buffer (1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 10 mM 
Tris pH 7.4, 150 mM NaCl). The beads were resuspended in 20 µL of resuspension buffer 
(4% SDS, 50 mM triethanolamine pH 7.4, 150 mM  NaCl) and 2.25 µL freshly premixed 
click chemistry reagents (same as above) were added. After 1 hour at room temperature, 
the reaction mixture was diluted with 8.7 µL 4× LDS sample buffer and 1.3 µL 2-
mercaptoethanol and separated by SDS-PAGE. A separate gel was loaded for Western 
blot analysis.
Sequential on-bead CuAAC. Lck and Fyn proteins were immunoprecipitated from 0.6-1 
mg of Jurkat cell lysate using antibodies described above. For HA-tagged H-RasG12V 
immunoprecipitation, 15 µL of anti-HA beads (Monoclonal anti-HA agarose conjugate, 
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clone HA-7) was added to 200-300 µg of HeLa cell lysates. After 2 hours incubation on a 
platform rocker at 4 °C, the beads were washed three times with 1 mL of ice-cold RIPA 
buffer. The beads were resuspended in 20 µL of PBS and 2.25 µL freshly premixed az-
rho click chemistry  reaction cocktail described above for a total approximate reaction 
volume of 25 µL for 1 hour at room temperature. The beads were washed three times with 
1mL of ice-cold RIPA buffer and resuspended in 20 µL of SDS buffer. For the second 
CuAAC reaction, 2.25 µL of freshly  premixed click chemistry reagents (alk-Cyfur in 
place of az-rho) were added. After 1 hour at room temperature, the reaction mixture was 
diluted with 8.7 µL 4× LDS sample buffer and 1.3 µL 2-mercaptoethanol, heated for 5 
min at 95 °C, and 20 µL was loaded per gel lane for separation by SDS-PAGE. A separate 
gel was loaded for Western blot analysis.
In-gel fluorescence scanning. Proteins separated by SDS-PAGE were visualized by 
incubating the gel in 40% methanol, 10% acetic acid for at least 1 hour and directly 
scanning it  on a GE healthcare Typhoon 9400 variable mode imager. Rhodamine-
associated signal was detected at excitation 532 nm/emission 580 nm while orthogonal 
detection of Cyfur-associated signal was achieved at excitation 633 nm/emission 670 nm. 
In-gel hydroxylamine treatment. After an initial fluorescence scan to determine 
pretreatment fluorescence, the gel was rinsed with deionized water and soaked in freshly 
prepared 1 M hydroxylamine (pH 7.4) for 2 hours at room temperature on a shaker. The 
gel was subsequently  rinsed with deionized water and incubated with shaking for 2 hours 
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in 40% methanol, 10% acetic acid at room temperature prior to scanning for post-
treatment fluorescence.
Western blots. Proteins separated by SDS-PAGE were transferred to nitrocellulose 
membranes (50 mM  Tris, 40 mM  glycine, 0.0375% SDS, 20% MeOH in deionized water, 
Bio-Rad Trans-Blot Semi-Dry Cell, 20 V, 40 min), which were blocked with 10% non-fat 
milk, 5% BSA, 0.1% Tween-20 in PBS (0.1% PBST) and washed with 0.1% PBST 
before incubation with appropriate antibodies. Membranes were incubated with a mouse 
anti-Lck (p56Lck) monoclonal (Clone 3A5, Invitrogen) followed by light chain-specific 
HRP-conjugated affiniPure goat anti-mouse secondary (Jackson Immunoresearch 
Laboratories) for anti-Lck blots. Likewise, anti-Fyn and anti-LAT blots were treated with 
mouse anti-Fyn monoclonal (S1, Chemicon) and mouse anti-LAT monclonal (2E9, 
Upstate) respectively and followed by goat anti-mouse HRP-conjugated secondary 
antibody (Upstate). Anti-HA blots were treated with rabbit anti-HA polyclonal 
(CloneTech) followed by  goat  anti-rabbit HRP-conjugated secondary antibody (Upstate). 
Anti-phosphotyrosine blots were blocked with 5% BSA, 0.1% PBST prior to incubation 
with HRP-conjugated anti-phosphotyrosine mouse monoclonal (PY99, Santa Cruz). Blots 
were developed using the enhanced chemiluminescent kit (GE Healthcare).
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Image processing and calculations. All images were processed and analyzed using the 
ImageJ software. A rectangular box was tightly selected around the band(s) of interest 
and average fluorescence intensity  at mid-length of the box was measured. Dimensions of 
the box were maintained within the same experiment. No event of signal saturation was 
observed in this study. Background signal from non-specific labeling was removed by 
subtracting measurements of the DMSO sample from each of the data points. The ratio of 
background-corrected alk-16 to az-12 associated fluorescent signals accounted for protein 
load and turnover at each time point of a pulse-chase analysis. To allow comparison 
between pulse-chase experiments, alk-16/az-12 values within each dataset were 
normalized such that alk-16/az-12=1 at T=0 hours, which was defined as the earliest  of 
three consecutive time points during which a decrease of alk-16/az-12 was initially 
observed. Since values obtained under some conditions tested did not form a straight line 
when plotted on a logarithmic scale, which was observed by others (50), data for each 
protein or chase condition was fitted to a two-phase exponential decay model using the 
KaleidaGraph graphing and data analysis software. The equation used was a biphasic 
exponential decay line m1*exp(-m2*m0)+m3*exp(-m4*m0), which starts at m1+m3 and 
decays with rate constants m2 and m4. The half-life of protein-bound palmitate (t1/2) was 
defined as the length time required for the normalized alk-16/az-12 signal to decrease 
halve if decay was to occur solely at the initial rate, which is ln(2)/m2 with m1=0.5.
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CHAPTER 3
RHEOSTATIC CONTROL OF PROTEIN PALMITOYLATION REGULATES 
MEIOTIC COMMITMENT IN FISSION YEAST
Introduction
With advancements in biochemical methods for the detection and identification of 
palmitoylated proteins, including those described in Chapter 2, it is evident that reversible 
protein palmitoylation is subjected to regulation in vivo at the level of individual proteins 
as well as the level of the palmitoylomes. Changes in the protein palmitoylation states 
and in the repertoire of modified proteins associated with different physiological states11, 
39, 54, 56 hint at the potential of this lipid modification to be a major cellular regulator akin 
to phosphorylation. Nonetheless, little is known of about how these changes are 
coordinated with physiological states and how they affect cellular function. 
 The family of DHHC-containing PATs is known to be responsible for most protein 
palmitoylation events and genes encoding PATs are found in all eukaryotes, ranging from 
a handful in unicellular fungi to more than twenty in metazoa (Fig. 3.1a, b). The multiple 
PATs in an organism raises intriguing questions about substrate specificity and regulation. 
Specific PATs were found to have different subcellular locations and tissue-specific 
distribution70, 71, suggesting the possibility that PATs play diverse roles in cells. 
Nonetheless, understanding their roles in regulating global palmitoylation and cellular 
physiology has been difficult due to extensive biochemical and functional overlap among 
multiple PATs12, 67-69.
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Figure 3.1 | Model  organisms used for PAT studies. a, Phylogenetic clustering of human and S. 
cerevisiae (Red) DHHC-containing PATs based on ClustalX alignment of the 51 amino acid 
DHHC core sequence. Six potential subfamilies (I-VI) are indicated by brackets. Adapted from 
Mitchell et  al.133 b, Model organisms used in PAT studies and the number of DHHC-containing 
PATs encoded in each genome. Blue: S. pombe PATs have not been studied.
 I chose to work in the fission yeast Schizosaccharomyces pombe because of its 
simple palmitoylation machinery compared to other model organisms that are 
traditionally  used in PAT studies (Fig. 3.1b). Like the budding yeast Saccharomyces 
cerevisiae, S. pombe is genetically amendable and has proven to be a useful model for 
fundamental principles and mechanisms such as cell cycle control, genome organization 
and signal transduction. Although studies of S. pombe PATs have not been reported, its 
simple PAT network should facilitate the functional dissection of individual PATs. A study 
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on compartmentalized Ras signaling provided further motivation to move into fission 
yeast. Onken et al. showed that the only  Ras protein in S. pombe, Ras1, controls cell 
morphology  and mating depending on its subcellular location, which in turn depends on 
its palmitoylation state28. The combination of a simple PAT network and a highly 
conserved protein substrate with distinct palmitoylation-dependent outputs that are easily 
scored make S. pombe an attractive model to study  basic control mechanisms of protein 
palmitoylation. 
 In this chapter, I showed that the chemical tools that we have previously 
developed in mammalian cells also works in fission yeast. Combining chemical and 
genetic approaches, I showed that physiological control of PAT levels underlies 
differential modification of its cognate substrates in distinct cellular states, shaping the 
palmitoylome, which in turn plays a critical role in meiotic commitment. Based on these 
results, I propose that rheostatic control of single or multiple PAT activities quantitatively 




S. pombe has a simplified PAT network
In contrast to metazoa and budding yeast, where high functional redundancy  among 
multiple PATs has been reported68, 69, the fission yeast genome contains only five open 
reading frames that encode proteins containing the conserved DHHC motif preceded by a 
cysteine-rich domain, which is a characteristic feature of PATs (Fig. 3.2a). This less 
complex PAT network allows me to more easily  dissect the functional contribution and 
regulation of individual PATs. 
Figure 3.2 | DHHC-PATs in S. pombe. a, Partial sequence alignments and consensus sequence 
of the five DHHC-containing PATs encoded in the S. pombe genome. Viability of null mutants are 
also indicated. b, Growth and morphological phenotypes of cells with individual PAT deletions. 
Notably, erf2∆ and erf4∆ cells are viable at 32 °C and 34 °C but  inviable at 36 °C. DIC images 
(Top panel) as well as measurements of cell lengths (n=20) at division and generation times 
(Bottom panel) of indicated strains.
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 Of the five PATs, only  Swf1 was essential for viability134 while deletions of the 
remaining PATs had no effect  on cell growth or morphology under exponential vegetative 
growth conditions at 32 °C. (Fig. 3.2). Notably, erf2∆ and erf4∆ cells are inviable at 36 
°C. I focused on the Erf2 PAT and its accessory protein Erf4, whose roles in meiosis are 
suggested by their strongly regulated expression during this major transitional event in 
fission yeast135, 136. This system, where PAT regulation is linked to a highly coordinated 
biological process, provides a good model to study  how regulation of PATs affects global 
protein palmitoylation and its functional consequences.
Erf2 PAT function regulates meiosis in S. pombe
Fission yeast cells proliferate in the haploid state but when nutrients become limiting, 
cells of opposite mating types conjugate to form a diploid zygote. These diploid cells 
replicate their genome and then undergo two successive nuclear divisions to yield four 
haploid nuclei that mature into spores, completing meiosis (Fig. 3.3a). To specifically 
investigate a potential role for Erf2 in meiosis as well as circumvent the mating defect of 
haploid erf2Δ cells (Fig. 3.6c), I constructed stable diploids containing a temperature-
sensitive allele of the Pat1 meiotic repressor, pat1-114, which can be used to 
synchronously induce meiosis137-139 (Fig 3.4a). Consistent with genome-wide expression 
studies135, 136, transcript levels of erf2 and erf4 were significantly upregulated in 
synchronized meiotic cells compared to vegetative cells (Fig. 3.3b). Expression of erf2 
and erf4 was also induced by overproduction of the meiosis-specific Mei4 transcription 
factor (Fig. 3.3c). Compared to erf2+ cells, erf2Δ mutants were delayed in meiotic entry, 
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as determined by the onset of S phase (Fig. 3.4b), and in meiotic progression (Fig. 3.4c, 
d). The striking increase in the length of erf2Δ cells suggests that they continued 
vegetative growth during this delay  (Fig. 3.4d). Taken together, these observations 
indicate a role for Erf2 in regulating meiotic entry, suggesting that changes in global 
protein palmitoylation are critical determinants in meiotic commitment.
Figure 3.3 |  erf2  and erf4  expression are strongly regulated during meiosis in fission yeast. a, 
Schematic representation of the fission yeast sexual differentiation process. Haploid cells 
conjugate to form a diploid zygote, which undergoes meiosis to yield four haploid nuclei that 
matures into spores. b, qPCR analysis of erf2 and erf4  transcripts in vegetative (Veg) and meiotic 
(Mei, 8 h after meiotic induction) pat1-114/pat1-114 cells. c, qPCR analysis of indicated 
transcripts in vegetative haploid cells overexpressing (OE) Mei4 from a thiamine-repressible 
promoter. Fold change, transcript levels after 24 hours in thiamine-free medium compared to that 
in thiamine-containing medium. mde5 is a known Mei4 target gene. b, c, All transcript  levels 
were normalized to act1 mRNA. Error bars, s.d. 
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Figure 3.4 | erf2Δ cells are delayed in meiotic entry. a, Pat1 is repressor of meiosis. 
Synchronous meiosis in diploid pat1-114/pat1-114 cells was induced by shifting nitrogen-starved 
cultures to restrictive temperature (see Methods). b, DNA content analysis of indicated strains 
after meiotic induction. c, d, Percentage of cells with 1, 2 or >2 nuclei were determined by 
counting ≥ 200 DAPI-stained cells of the indicated strains at  hourly intervals after meiotic 
induction (left  panel). Shaded area facilitates comparison between the two strains. Representative 
DIC (middle panel) and DAPI (right panel) images of cells at indicated times after temperature 
shift. Scale bars, 10 µm.
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Chemical tools also work in fission yeast
To assess Erf2-dependent modulation of the palmitoylome during meiosis, we employed 
the alkyne-functionalized palmitate chemical reporter described in Chapter 2, alk-16140, 
together with bioorthogonal labeling (Fig. 3.5a), which allows superior fluorescent 
detection of the modification compared to conventional radiolabeled lipids in mammalian 
and yeast  cells (Fig. 3.5b-d). This bipartite bioorthogonal labeling approach enabled 
robust visualization of global and individual palmitoylated proteins such as Ras1 without 
overexpression (Fig. 3.5b). Alk-16 labeling of Ras1 was competed away  by palmitic acid 
in a dose-dependent manner (Fig. 3.5c). Additionally, preincubating cells with broad-
spectrum palmitoylation inhibitor 2-bromopalmitate or post-CuAAC cleavage of 
thioesters with hydroxylamine greatly diminished the fluorescence signal observed for 
Ras1 (Fig. 3.5d). In contrast, pretreating cells with protein synthesis inhibitor 
cycloheximide had minimal effect on Ras1 labeling (Fig. 3.5d). Collectively, these 
experiments established alk-16 as a specific and robust reporter for post-translational 
protein S-palmitoylation in fission yeast at endogenous substrate and enzyme 
concentrations.
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Figure 3.5 | Chemical tools work in fission yeast. a, Schematic representation of the 
bioorthogonal detection protocol. Alk-16: alkyne-functionalized palmitate reporter. Az-rho: azide-
functionalized rhodamine fluorophore. CuAAC: copper-catalyzed azide-alkyne cycloaddition. b, 
In-gel fluorescent  detection of alk-16 labeled proteins in lysates and immunopurified Ras1. c, d, 
Fluorescent detection of immunopurified Ras1, a known palmitoylated protein, from alk-16 
labeled cells (top panels). Western blots are probed for Ras1 (bottom panels). Palmitate (Palm) 
competes with alk-16 labeling in a dose-dependent manner. Ras1 fluorescence signal was greatly 
diminished by preincubating cells with a general palmitoylation inhibitor 2-bromopalmitate (2BP) 
or by post-CuAAC cleavage of palmitoylation thioester linkages with hydroxylamine (NH2OH). 
Pretreatment of cells with the protein synthesis inhibitor cycloheximide (CHX) had little effect on 
post-translational Ras1 labeling by alk-16.
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Ras1 is a substrate of the Erf2-Erf4 PAT complex
Using this system, I showed that the Erf2-Erf4 PAT complex and not two of the other 
putative PATs is required for the incorporation of alk-16 onto Ras1 (Fig. 3.6a), a known 
palmitoylated protein whose modification has been implicated in pheromone signaling28. 
Incorporation of alk-16 directly requires Erf2 PAT activity as re-introduction of Erf2, but 
not a catalytically  inactive DHHC➞DHHA mutant58, 62, rescued the Ras1 palmitoylation 
defect in erf2Δ cells (Fig. 3.6b). Since palmitoylation of Ras1 has been implicated in 
pheromone signaling28, these observations are consistent  with the mating defect of erf2Δ 
cells (Fig. 3.6c).  Akr1 may substitute for Erf2 function since deletion of akr1 in an erf2Δ 
background further decreased mating efficiency although no mating defect  was observed 
for akr1Δ cells. This is not surprising given the redundancy  between the multiple budding 
yeast and mammalian PATs68, 69. Collectively, these experiments demonstrate that Erf2-
Erf4 is able to specifically incorporate alk-16 into its substrates and that this method can 
be used to profile Erf2 substrates.
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Figure 3.6 |  Ras1 is a substrate of the  Erf2-Erf4 PAT complex. a, b, Alk-16-associated 
fluorescence of immunopurified Ras1 from cells with the indicated PAT deletions (top panels). 
Western blots are probed for Ras1 (bottom panels). Wild type (DHHC) or catalytic inactive 
(DHHA) Erf2 was expressed from a thiamine-repressible promoter in erf2Δ cells. c, erf2Δ and 
erf4Δ cells are defective in mating. Mating efficiency is quantified as the percentage of diploid 
zygotes/spore-containing asci after 2 days in nitrogen-free medium normalized to wild type 
(n≥200). Error bars, s.d. 
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Erf2 drives changes in the palmitoylome during meiosis
The significantly elevated erf2 transcript levels in meiotic cells and the phenotypes of 
erf2Δ cells support its role in orchestrating meiosis-specific protein palmitoylation (Fig. 
3.3). To determine whether increased erf2 expression alone has an impact on the meiotic 
palmitoylome, I profiled palmitoylated proteins by in-gel fluorescence in diploid cells 
undergoing synchronous meiosis. A distinct meiotic palmitoylome with a prominent band 
at approximately 23 kDa is established following the striking increase in Erf2 protein 
levels (Fig. 3.7a), which reflects the reported erf2 transcription profile during meiosis135, 
136. This specific palmitoylome requires Erf2 activity, as modification of those prominent 
substrates was not observed in either erf2Δ or erf4Δ cells undergoing meiosis (Fig. 3.7b, 
c). Ras1 was also palmitoylated in an Erf2-Erf4 dependent manner in meiotic cells (Fig.
3.7c, lower panel), suggesting a role for Ras1 in meiosis141. Since the salient features of 
the meiotic palmitoylome were still observed when two of the other putative PATs are 
deleted (Fig. 3.7c), I concluded that Erf2 is the primary PAT driving changes in the 
protein palmitoylation during meiosis.
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Figure 3.7 | The  Erf2-Erf4 PAT is  required for meiotic-specific protein palmitoylation. a, b, 
Fluorescence profiles of palmitoylated substrates in erf2-HA3/erf2-HA3 pat1-114/pat1-114 and 
erf2∆/erf2∆ pat1-114/pat1-114 cells undergoing synchronized meiosis (top panels). At  the 
indicated times after meiotic induction, aliquots of the culture were pulse-labeled with alk-16. 
Western blots were probed for tubulin and HA (middle and bottom panels). c, Fluorescence 
detection of palmitoylated substrates (top panel) and Ras1 palmitoylation (bottom panel) in 
homozygous diploid pat1-114/pat1-114 cells with the indicated PAT  deletions 8 h after meiotic 
induction. (-): DMSO control. Veg: vegetative cells. Red arrowhead points to the major substrate 
~25 kDa that is specifically modified by Erf2 in meiotic cells.
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Isp3 and Rho3 are selectively palmitoylated by Erf2 in meiotic cells
To identify the major Erf2 substrates that are preferentially palmitoylated during meiosis, 
I affinity purified alk-16 labeled proteins in meiotic erf2+, vegetative erf2+, and meiotic 
erf2Δ cells using a cleavable azido-biotin tag (Supplementary Fig. 3.8a, b). Recovered 
proteins were subsequently identified by gel-based proteomics, and those with ≥ 2-fold 
spectral counts in alk-16 samples compared to the corresponding DMSO controls were 
further studied. Proteins enriched in meiotic erf2+ cells were subjected to two filter 
criteria, excluding those also enriched in (1) meiotic erf2Δ cells and (2) vegetative erf2+ 
cells (Fig. 3.8c). Notably, Ras1 was excluded by  the second filter because it was equally 
recovered in both meiotic and vegetative erf2+ cells, consistent with the biochemical 
analyses (Fig. 3.9d). Of the 238 remaining candidates (Appendix 1), we focused on Isp3 
and Rho3 (Fig. 3.8e) as they were the most highly enriched proteins with molecular 
weights matching the prominent ~23 kDa band we previously observed (Fig. 3.8d). 
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Figure 3.8 | Identification of Erf2 substrates that are selectively palmitoylated during 
meiosis. a, Schematic representation of the selective enrichment  protocol of alk-16 modified 
proteins from cell lysates using streptavidin beads. Az-azo-biotin: Azide-functionalized biotin 
probe with an azobenzene cleavable linker. CuAAC: copper-catalyzed azide-alkyne 
cycloaddition. b, c, Filter criteria for candidate substrates that  are palmitoylated by Erf2 during 
meiosis. d, Each of the 238 candidates from (c) is represented as a data point reflecting its 
molecular weight and enrichment  (net  spectral counts) in alk-16 over DMSO labeled erf2+ 
meiotic cells. Isp3 and Rho3 are the top two candidates with molecular weights ~23 kDa 
(shaded). e, Amino acid sequences of Rho3 and Isp3, both of which were validated to be Erf2 
substrates that  are selectively palmitoylated in meiotic cells. Yellow: identified peptides. Green: 
modified amino acids in identified peptides (e.g. oxidation, carbamidomethylation).
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Cognate Erf2 substrates are differentially modified in distinct cellular states
Isp3, an abundant spore protein specifically  expressed in meiotic cells142 (Fig. 3.9c), was 
the most heavily modified species since the ~23 kDa band was lost in isp3Δ cells and 
HA3-tagging of Isp3 reduced the electrophoretic mobility of the major fluorescent band 
(Fig. 3.9a). I also confirmed that Rho3, a Rho GTPase involved in polarized growth143, is 
an Erf2 substrate (Fig. 3.9b) that is differentially modified with between meiotic and 
vegetative cells (Fig. 3.9d). This suggests a mechanism by which changes in the 
palmitoylome can be mediated by the regulation of a single PAT (Fig. 3.9e). Given that 
Erf2 expression is low in vegetative cells and high in meiotic cells, I reasoned that the 
differential modification of Erf2 substrates could be a consequence of PAT levels.
73
Figure 3.9 | Erf2 substrates are differentially modified in vegetative  and meiotic cells. a, 
Fluorescence profiles of meiotic cells with indicated gene deletions or those expressing 
endogenous or tagged Isp3 (top panels). Control: isp3+ cells labeled with DMSO instead of 
alk-16. Bottom panels: Coomassie or western blot probed for HA. b, Palmitoylation of Rho3-HA3 
in meiotic erf2+ and erf2Δ cells (top panel). Western blot is probed for HA (bottom panel). c, 
Isp3-HA3 expression as determined by anti-HA blot of lysates from cells in indicated cellular 
states. Veg: vegetative cells. Mei: meiotic cells. d, Rho3 and Ras1 palmitoylation states in 
vegetative and meiotic cells (top panels). Western blots were probed for Ras1 or HA (bottom 
panels). a-d, Synchronous meiosis in indicated diploid pat1-114/pat1-114 cells was induced by 
shifting nitrogen-starved cultures to restrictive temperature (see Methods). Meiotic cells refer to 
cells 8 h after the temperature shift. e, While differential palmitoylation of Isp3 in meiotic and 
vegetative cells can be explained by meiosis-specific isp3 expression, the differential 
modification of Ras1 and Rho3 is mediated by an alternative mechanism. Yellow circles represent 
palmitoylation of the indicated Erf2 substrates.
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Erf2-Erf4 PAT levels shape the meiotic palmitoylome
To test this hypothesis, I reduced erf2 expression in diploid cells undergoing 
synchronized meiosis, achieving intermediate and low expression relative to wild type 
(Fig. 3.10a, top). Although all three substrates require Erf2 for palmitoylation, Ras1, 
Rho3 and Isp3 were differentially  modified as a consequence of altering erf2 levels (Fig. 
3.10a). Ras1 was efficiently palmitoylated at  low erf2 expression levels, and its 
palmitoylation was unaltered at higher levels. In contrast, reducing erf2 expression 
decreased Rho3 and Isp3 palmitoylation with different sensitivities. This demonstrates 
that modulation of PAT levels can differentially alter the palmitoylation of individual 
substrates and suggests that the strong upregulation of erf2 expression during meiosis is 
needed to establish the distinctive features of the meiotic palmitoylome.
If physiological control of Erf2-Erf4 abundance solely accounts for the 
palmitoylome changes observed upon meiosis, it is predicted that increasing Erf2-Erf4 
levels in haploid vegetative cells would yield a palmitoylome similar to that of meiotic 
cells. To test this, I focused on Ras1 and Rho3 as model substrates since isp3 expression 
is restricted to meiotic cells (Fig. 3.9c). Ras1 palmitoylation was insensitive to increases 
in Erf2-Erf4 levels (Fig. 3.10b), consistent with our results in meiotic cells. In contrast, 
while individual overexpression of erf2 and erf4 had no impact on Rho3 modification, a 
striking increase in Rho3 palmitoylation was observed when the effective Erf2-Erf4 PAT 
concentration was increased by  co-overexpression of erf2 and erf4 (Fig. 3.10b, strains 
4-7). Intermediate overproduction of Erf2-Erf4 resulted in a modest increase in Rho3 
palmitoylation, indicating a dose-dependent function of PAT activity (Fig. 3.10b, strain 
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8). Importantly, although erf2 and erf4 were expressed from heterologous promoters, 
their levels were in fact within physiological range, with the highest and lowest levels 
being comparable to those attained by meiotic and vegetative cells respectively  (Fig. 3.3b 
and 3.10a, b). These results demonstrate that rheostatic control of protein palmitoylation 
by varying PAT levels is a mechanism by which cells finely  shape the palmitoylome and 
that this may play a key role in cellular transitions such as meiosis.
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Figure 3.10 |  Physiological changes in Erf2-Erf4 levels underlie the differential modification of 
cognate substrates in meiotic and vegetative cells. a, Labels are indicated in box. qPCR analysis of erf2 
and erf4 transcripts normalized to act1 mRNA levels in indicated pat1-114/pat1-114 strains 8 h into 
synchronous meiosis (top panel). Error bars, s.d. Palmitoylation of cognate Erf2 substrates were analyzed 
from the same lysate of each strain (bottom panels). Ras1 and Rho3-HA3 were immunopurified and their 
levels were determined by Ras1 and HA immunoblots respectively. Isp3 palmitoylation was monitored at 
the lysate level since it accounts for most of the fluorescence at ~23 kDa (Isp3 is unstable upon 
immunoprecipitation, data not shown). b,  Labels are indicated in box. Overexpression of erf2 and/or erf4 
from thiamine-repressible nmt promoters in the indicated vegetative pat1-114 cells was achieved by 
switching them into thiamine-free medium for 24 h. qPCR analysis (top panel) as well as palmitoylation of 
Ras1 and Rho3 (bottom panels) were performed as described in (a). Isp3 is not expressed in vegetative 
cells.Cells were maintained at permissive temperature throughout this experiment (See Methods). c, DAPI 
(left) and DIC (right) images of indicated cells 96 h after erf2 and/or erf4 overexpression. Strain 7*: nmt1-
erf2 (DHHA) nmt1-erf4. Scale bars, 10 µm.
77
Erf2-Erf4 overproduction is sufficient to induce a meiotic phenotype in vegetative cells
If PAT-mediated changes in global protein palmitoylation are critical in meiotic entry, 
then increasing Erf2-Erf4 levels in vegetative cells may be sufficient to trigger meiosis in 
the absence of nutritional cues. Strikingly, overexpression of erf2 and erf4 in proliferating 
haploid cells induced a meiotic phenotype (Fig. 3.10c, strain 7). A significant reduction in 
growth rate with time, accompanied by a reduction in cell length at division and a 
transient G1 delay (Fig. 3.11a-c) was observed. At 96 hours after induction, a significant 
proportion of cells had >2 nuclei (Fig. 3.11d). These cells were appeared to be 
undergoing a meiotic program since deletion of mei4, which is required for meiotic but 
not mitotic divisions, resulted in the disappearance of cells with >2 nuclei and 
accumulation of misshapen cells with a single nucleus (Fig. 3.11f). The appearance of 
spores that are resistant to β-glucuronidase digestion, which specifically kills vegetative 
cells further suggested that these cells were indeed undergoing sexual differentiation 
program (Fig. 3.11e). While Erf2-induced haploid meiosis produced mainly inviable 
spores, overexpression erf2 and erf4 in diploid cells also induced a meiotic phenotype 
and yielded viable spores (Fig. 3.13). Under these same conditions, non-overexpressing 
cells continued normal vegetative growth over the course of the experiment (Fig. 3.12). 
Overall, these results demonstrate that increasing the levels of a single PAT activity is 
sufficient to induce sexual differentiation in otherwise proliferating cells and implicate 
the control Erf2-Erf4 activity  levels as a major determinant in S. pombe meiotic 
commitment.
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Figure 3.11 | Overproduction of Erf2 and Erf4 in proliferating cells  induce  a meiotic 
phenotype. a-e, erf2 OE erf4 OE: strain 7 from Fig. 3.10 that  co-overexpresses erf2  and erf4 at 
high levels. These cells were grown in the presence of nutrients at  permissive temperature, and 
co-overexpression of erf2 and erf4 was induced by switching cells to thiamine-free medium (See 
Methods). Indicated times or time intervals refers to time after induction of erf2  and erf4 co-
overexpression. a, Fold change in OD595 of cultures during indicated 12 h intervals. OD595 was 
maintained < 0.6 (See Methods). b, DNA content analysis. c, Blankophor staining of cells (top 
panels). Dimensions of septated cells (cell length and width, n=20) and percentage of septated 
cells (septation index, n≥200) were determined by measuring and counting blankophor-stained 
cells (bottom panels, left  to right). Error bars, s.d. d, Percentage of cells with 1, 2 or >2 nuclei 
(n≥200) was determined by DAPI staining. e, Left  panel, percentage of cells with spores (n≥200) 
at  indicated times post-induction. Right panel, DIC images of cells 96 h post-induction before and 
after β -glucuronidase digestion, which specifically kills vegetative cells but not  spores. f, DAPI 
(top) and DIC (bottom) images of indicated erf2  and erf4  co-overexpressing cells 96 h post-
induction. Scale bars, 10 µm. 
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Figure 3.12 | Non-overexpressing pat1-114 cells continue vegetative  growth  under the  same 
conditions. erf2 OE erf4 OE: strain 7 from Fig. 3.10 that co-overexpresses erf2 and erf4 at high 
levels. erf2 erf4: strain 4 from Fig. 3.10 that expresses erf2 and erf4 at endogenous levels. These 
cells were grown in the presence of nutrients at  permissive temperature, and co-overexpression of 
erf2 and erf4 was induced by switching cells to thiamine-free medium (See Methods). Indicated 
times or time intervals refers to time after the switch to thiamine-free medium. a, Fold change in 
OD595 of cultures during indicated 12 h intervals. OD595 was maintained < 0.6 (See Methods). b, 
DNA content analysis. c, Blankophor staining of cells (left  panels).Scale bars, 10 µm. Dimensions 
of septated cells (cell length and width, n=20, middle panels) and percentage of septated cells 
(septation index, n≥200, right  panel) were determined by measuring and counting blankophor-
stained cells. Error bars, s.d. d, Percentage of cells with 1, 2 or >2 nuclei (n≥200) was determined 
by DAPI staining of the indicated strains. e, Percentage of cells with spores at  indicated times 
post-induction (n≥200). 
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Figure 3.13 |  Ectopic meiosis  in diploid cells co-overexpressing erf2 and erf4 yields viable 
spores. Strain 7 from Fig. 3.10 was diploidized and grown in the presence of nutrients at 
permissive temperature, and co-overexpression of erf2 and erf4 was induced by switching cells to 
thiamine-free medium (See Methods). Indicated times or time intervals refers to time after the 
switch to thiamine-free medium. a, Fold change in OD595 of cultures during indicated 12 h 
intervals. OD595 was maintained < 0.6 (See Methods). b, DNA content analysis. c, Blankophor 
staining of cells (top panels). Dimensions of septated cells (cell length and width, n=20) and 
percentage of septated cells (septation index, n≥200) were determined by measuring and counting 
blankophor-stained cells (bottom panels, left to right). Error bars, s.d. d, Percentage of cells with 
1, 2 or >2 nuclei (n≥200) was determined by DAPI staining (left panel). DAPI and DIC images of 
cells 96 h post-induction (right panels). e, DIC image of cells 96 h post-induction after β-
glucuronidase digestion, which specifically kills vegetative cells but not spores. f, Percentage of 
cells with spores (n≥200). Viable colonies were obtained after plating β -glucuronidase digested 
cells at 84 h and 96 h. Scale bars, 10 µm.
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Erf2-induced meiotic phenotype is dependent on PAT activity levels
Consistent with the rheostat model (Fig. 3.10), this meiotic phenotype was dependent on 
high PAT levels, as cells continued vegetative growth when erf2 and erf4 are expressed at 
low (Fig. 3.11f, +Thiamine) or intermediate levels (Fig. 3.10c, strain 8). Critically, 
meiotic induction was not observed in cells co-overexpressing a catalytically  inactive 
Erf2 mutant and Erf4 (Fig. 3.10c, strain 7*) or in cells overproducing either Erf2 or Erf4 
alone (Fig. 3.10c, strains 5 and 6), highlighting the requirement for a functional and 
active PAT complex. Together with the meiotic delay observed in erf2Δ cells, these 
results demonstrate that  modulation of Erf2-Erf4 activity levels through changes in the 
expression of each subunit is a key step for meiotic commitment.
Rho3 function is required for Erf2-induced meiosis
As erf2 and erf4 expression are upregulated in cells undergoing normal meiosis when 
encountering low nitrogen conditions136, these results suggest that PAT level-mediated 
modulation of the palmitoylome is a major determinant of meiotic entry. What are the 
cellular factor(s) involved in this process? As meiosis can be induced by Erf2-Erf4 
overproduction, I reasoned that Erf2-Erf4 substrates involved in triggering meiosis would 
have to be present in vegetative cells and sensitive to Erf2-Erf4 levels for their 
palmitoylation state (Fig. 3.14a). One such substrate is Rho3 (Fig. 3.9b, d, and 3.10b). I 
found that Rho3, but not Ras1, is required for the meiotic phenotype triggered by  Erf2-
Erf4 overexpression in haploid cells (Fig. 3.14b). This is clearly dependent on the Exo70 
subunit of the exocyst complex and the Formin For3 (Fig. 3.14b), both effectors of Rho3, 
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suggesting a novel role for Rho3 in meiotic control in fission yeast, potentially  through 
its function in polarized exocytosis that is likely to be regulated by its palmitoylation 
state143, 144.
Figure 3.14 | A novel function of Rho3 in  S. pombe meiotic control. a, As meiosis can be 
induced by Erf2-Erf4 overproduction, the cellular factor(s) involved in Erf2-mediated meiotic 
control should be present in vegetative cells. Yellow circles represent  palmitoylation of the 
indicated Erf2 substrates. b, DAPI (top) and DIC (bottom) images of erf2 and erf4 co-
overexpressing cells with indicated deletions 96 h post-induction. Scale bars, 10 µm. Rho3 in S. 
pombe regulates polarized cell growth through For3 and Exo70, both of which are required for 
the observed meiotic phenotype. Rho3 has also been implicated in Golgi/endosome trafficking 
through Apm1 but Apm1 function is not required for Erf2-Erf4 induced meiosis.
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Erf2 function is required for proper Rho3 localization in vegetative and meiotic cells
Since palmitoylation has been shown to control protein function by changing protein 
distribution between the plasma and intracellular membranes, in collaboration with Dr. 
Pei-Yun Jenny Wu, we asked if Erf2-mediated palmitoylation of Rho3 affects its 
subcellular localization during ectopic meiosis. While Rho3 normally localizes to cell tips 
and septa in vegetative cells144, enhanced enrichment at cell tips was observed with Erf2-
Erf4 overexpression (Fig. 3.15a), which coincided with increased Rho3 palmitoylation 
(Fig. 3.10b). Interestingly, Rho3 relocalized to what  appeared to be prespore surfaces 
encapsulating individual nuclei as cells completed meiosis (Fig. 3.15a). This 
redistribution of Rho3 from cell tips to prespore surfaces was also observed under more 
physiological conditions, during meiosis in diploid cells induced by Pat1 inactivation 
after nitrogen starvation (Fig. 3.15b). Rho3 localization in both vegetative and meiotic 
cells requires palmitoylation by Erf2 (Fig. 3.15c), which was also visualized at forespore 
surfaces during meiosis (data not shown). Taken together, these data suggest that Erf2-
Erf4 regulates Rho3 function, and potentially its role in polarized exocytosis, by  altering 
its subcellular distribution.
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Figure 3.15 | Erf2-dependent Rho3 
localization in vegetative  and 
meiotic cells. Immunofluorescence 
localization of Rho3-HA3 and DAPI 
images (left  panels). Background 
anti-HA immunofluorescence and 
respective DAPI images (right 
panels). Images are maximum 
intensity projections. Scale bars, 10 
µm. a, Haploid cells were grown in 
the presence of nutr ients at 
permiss ive tempera ture . Co-
overexpression of erf2 and erf4 (erf2 
OE erf4 OE) was induced by 
switching cells to thiamine-free 
medium (See Methods). Indicated 
times refers to time after the switch 
to thiamine-free medium. b, c, 
Meiosis in homozygous diploid 
pat1-114/pat1-114 cells with the 
indicated genotypes was induced by 
shifting the culture to restrictive 
temperature for the indicated times. 
Later time points were taken for 
erf2Δ cells to compensate for the 




In this chapter, we demonstrated that PAT levels matter. Physiological control of PAT 
levels underlie the differential modification of distinct  substrates in vegetative and 
meiotic cells and palmitoylome changes mediated by control of the level of Erf2-Erf4 
activity are sufficient to induce meiosis in fission yeast. We propose that rheostatic 
control of single or multiple PAT activities quantitatively regulates palmitoylomes, which 
we showed have important consequences on cellular events.
 This study showcases fission yeast  as a relevant and complementary  model 
organism for PAT studies. Consistent with studies in budding yeast and mammals12, 65, 67, 
I showed that fission yeast PATs can have different substrate preferences and that specific 
PAT-substrate pairs are needed for efficient palmitate transfer. Notably, the Erf2-
Erf4:Ras1 PAT:substrate pairing in fission yeast is reminiscent of the ERF2-ERF4:RAS1/
RAS2 and DHHC9-GCP16:H-/N-Ras pairs in budding yeast and human, respectively 58, 
59. This suggests an evolutionary selection for specific cognate PAT:substrate pairs, which 
would be unlikely  if PATs have extensive overlapping substrate preferences and were able 
to freely substitute for each other. Furthermore, from the relatively few PAT paralogs in 
fission yeast, I surmised that there would be less functional redundancy  between the 
enzymes, enabling us to distinguish the functional contributions of individual PATs. This 
is evident from the requirement of Swf1 for cell viability, which is the first report  of an 
essential DHHC-PAT and supports the view that  PATs occupy functional niches. 
Furthermore, I showed biochemically a clear requirement for Erf2 in Ras1 and Rho3 
palmitoylation in fission yeast, in contrast to reports in budding yeast12, 63. The 
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unambiguous PAT-substrate pairs in fission yeast facilitated this study and given the 
apparent parallels of PAT-mediated protein palmitoylation between yeasts and metazoa, 
studying this simple machinery  will provide insights into equivalent controls in 
mammals.
It remains to be determined how levels of a PAT affect its substrate specificity. 
One possibility is a difference in catalytic efficiency (kcat/KM) and this is supported by the 
discovery  of specificity  determinants on both the PATs and their substrates that dictate 
enzyme-substrate interactions66, 67. In addition, level-dependent changes in PAT 
localization might alter substrate availability. For example, DHHC2 translocates to post-
synaptic membranes upon neuronal stimulation, where it increases palmitoylation and 
synaptic targeting of PSD9551. In this study, however, changes in PAT localization are 
unlikely to account for the difference in Ras1 and Rho3 palmitoylation since both 
substrates are localized to the same compartments in vegetative cells28, 144. Alternatively, 
there may  be depalmitoylating thioesterases or competing cellular factors that target 
substrates differentially40, 84, 86, 87. 
As global proteomic studies rapidly expand the known list of proteins that are 
reversibly modified with this lipid moiety10-18, palmitoylation is proposed to be a major 
cellular regulator. This is supported by  expression profiling experiments in flies and 
humans in which transcript levels of specific PATs vary widely across tissues70, 71. 
Neuronal differentiation signals were found to induce the PAT degradation via the 
ubiquitin-proteosome pathway74. In addition, PAT overexpression is associated with a 
variety of human cancers and induces cellular transformation (summarized in Table 1.2). 
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Along with these results, this study suggests critical roles for the control of PAT levels 
and regulation of palmitoylomes in cellular development and disease. Although the 
palmitoylation machinery is more elaborate in multicellular eukaryotes, the conservation 
of PAT function and of specific PAT:substrate pairs between yeast and humans12, 58, 59 
indicates that the conclusions of this study  are relevant in predicting regulatory  roles of 
palmitoylation in major developmental transitions in metazoa.
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Materials and Methods
Genotype of haploid S. pombe strains used.
Strain Genotype Source
PN1 h- Nurse lab 
PN4 h+ Nurse lab
Mz53 h- erf2Δ::NatMX6 This study
Mz56 h+ erf2Δ::NatMX6 This study
Mz166 h- erf4Δ::KanMX6 This study
Mz170 h+ erf4Δ::KanMX6 This study
Mz126 h- akr1Δ::KanMX6 This study
Mz132 h+ akr1Δ::KanMX6 This study
Mz120 h- pfa5Δ::KanMX6 This study
Mz124 h+ pfa5Δ::KanMX6 This study
Mz184 h- erf2Δ::NatMX6 erf4Δ::KanMX6 This study
Mz188 h+ erf2Δ::NatMX6 erf4Δ::KanMX6 This study
Mz254 h- akr1Δ::KanMX6 pfa5Δ::KanMX6 This study
Mz257 h+ akr1Δ::KanMX6 pfa5Δ::KanMX6 This study
Mz108 h+ erf2Δ::NatMX6 leu1-32::pDUAL(leu1 nmt41:HFY-erf2) ade-M216 ura4-D18 This study
Mz199 h+ erf2Δ::NatMX6 leu1-32::pDUAL(leu1 nmt41:HFY-erf2(DHHA)) ade-M216 ura4-D18 This study
YN464 
(FY12642)* h- leu1 pREP1(nmt1:mei4)
Nakase et 
al.197
Mz471 h- pat1-114 nmt1:erf2::KanMX6 rho3-HA3::KanMX6 This study
Mz492 h- pat1-114 nmt1:erf4::KanMX6 rho3-HA3::KanMX6 This study
Mz476 h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 rho3-HA3::KanMX6 This study
Mz504 h- pat1-114 nmt41:erf2::KanMX6 nmt41:erf4::KanMX6 rho3-HA3::KanMX6 This study
Mz556 h- pat1-114 leu1-32::pDUAL(leu1 nmt1:erf2(DHHC)) This study
Mz560 h- pat1-114 leu1-32::pDUAL(leu1 nmt1:erf2(DHHA)) This study
Mz518 h- nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 rho3-HA3::KanMX6 This study
Mz534 h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 mei4Δ::natMX6 ura4-D18 This study
Mz488 h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 rho3Δ::kanMX6 ura4-D18 This study
Mz587 h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 ras1Δ::ura4
+ 
ura4-D18 This study
Mz629 h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 apm1Δ::ura4
+ 
ura4-D18 This study
Mz634 h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 exo70Δ::ura4
+ 
ura4-D18 This study




Genotype of  diploid S. pombe strains used.
Strain Genotype Source
Mz5d h-/h- pat-114/pat1-114 erf2-HA3::KanMX6/erf2-HA3::KanMX6 This study
Mz9d h-/h- pat-114/pat1-114 erf2Δ::NatMX6/erf2Δ::NatMX6 This study
Mz21d h-/h- pat-114/pat1-114 erf4Δ::KanMX6/erf4Δ::KanMX6 This study
Mz25d h-/h- pat-114/pat1-114 akr1Δ::KanMX6/akr1Δ::KanMX6 This study
Mz29d h-/h- pat-114/pat1-114 pfa5Δ::KanMX6/pfa5Δ::KanMX6 This study
Mz17d h-/h- pat-114/pat1-114 akr1Δ::KanMX6/akr1Δ::KanMX6 pfa5Δ::KanMX6/pfa5Δ::KanMX6 This study
Mz60d h-/h- pat-114/pat1-114 ras1Δ::KanMX6/ras1Δ::KanMX6 This study
Mz74d h-/h- pat-114/pat1-114 isp3Δ::KanMX6/isp3Δ::KanMX6 This study
Mz64d h-/h- pat-114/pat1-114 rho3Δ::KanMX6/rho3Δ::KanMX6 This study
Mz88d h-/h- pat-114/pat1-114 isp3-HA3::KanMX6/isp3-HA3::KanMX6 This study
Mz68d h-/h- pat-114/pat1-114 rho3-HA3::KanMX6/rho3-HA3::KanMX6 This study
Mz89d h-/h- pat-114/pat1-114 rho3-HA3::KanMX6/rho3-HA3::KanMX6 erf2Δ::NatMX6/erf2Δ::NatMX6 This study
Mz129d h-/h- pat1-114/pat1-114 nmt41:erf2::KanMX6/nmt41:erf2::KanMX6 rho3-HA3::KanMX6/rho3-HA3::KanMX6 This study









*Strain was obtained from the Yeast Genetic Resource Center of Japan, supported by  the 
National Bioresource Project (YGRC/NBRP).
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Strain construction and growth conditions. Standard media and methods were used145, 
146. All experiments were carried out in minimal medium (EMM) and minimal medium 
plus supplements (EMM4S) for prototrophic and auxotrophic strains respectively at 25 
°C unless otherwise noted. When applicable, strains were generated by tetrad dissection 
and validated by marker segregation or PCR. Deletion strains, strains expressing erf2-
HA3, isp3-HA3, and those expressing erf2 and erf4 from nmt promoters were constructed 
by PCR integration147. For Rho3, the HA3-tag sequence was inserted in-frame 42 bp 
upstream of its termination codon by PCR integration. Functional rescue in erf2Δ cells 
was performed using the pDUAL plasmid (RIKEN BRC, Japan) expressing YFP-FLAG-
His6-erf2 under the nmt41 promoter, which was linearized and integrated into the leu1 
locus. The Quikchange XL II kit (Stratagene) was used for site-directed mutagenesis of 
the erf2 DHHC motif. Homozygous diploids were obtained by incubating midlog cultures 
of haploid cells with 20 µg/ml Carbendazim (Sigma) for 4.5 hours at 25 °C and screening 
colonies on YES + phloxin B plates.
Synchronized Pat1-driven meiosis. Pat1-driven meiosis in diploid pat1-114/pat1-114 
cells was carried out as described135. Midlog cultures grown in EMM, which contains 
0.5% NH4Cl, were filter-washed three times with nitrogen-free minimal medium (EMM-
N) using the Microfil filtration system (Millipore), and resuspended in EMM-N for 14 
hours at 25 °C. Meiosis was induced by  shifting the cultures to 34 °C in the presence of 
0.05% NH4Cl. t=0 is defined as the time of the temperature shift.
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erf2 and/or erf4 overexpression from thiamine-repressible nmt promoters. Cultures 
were grown to midlog in EMM plus 10 mg/mL thiamine at 25 °C. erf2 and/or erf4 
expression from nmt promoters was induced by filter-washing the cells three times with 
EMM as described above. The cells were resuspended in EMM and growth was 
maintained at 25 °C. The cultures were diluted with EMM approximately every 12 hours 
for the duration of each experiment to keep OD595 <0.6 and in the presence of nutrients. 
t=0 is defined as the time of thiamine removal.
Flow cytometry. DNA content was analyzed by flow cytometry  using ethanol-fixed and 
propidium iodide-stained cells (2 µg/mL propidium iodide in 50 mM sodium citrate) on a 
BD FACS Calibur and analyzed using FlowJo software.
Cell size measurements and DNA staining. For cell size measurements, live cells were 
stained with Blankophor (MP Biomedicals). For DNA staining, ethanol-fixed cells were 
stained with DAPI. Images were acquired in Metamorph (MDS Analytical Technologies) 
using an Axioplan 2 microscope (Carl Zeiss) and a CoolSNAP HQ camera (Roper 
Scientific). Cell size measurements were obtained using the Pointpicker plug-in of Image 
J (National Institute of Health).
Immunofluorescence microscopy. Cells were fixed at the indicated time points in 3.7% 
formaldehyde for 30 minutes at 25 ºC, washed three times in PEM (100 mM Pipes, 1 mM 
EGTA, 1 mM  MgSO4 pH 6.9), and digested with 0.25 mg/mL zymolyase in PEMS (PEM 
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+ 1.2 M Sorbitol) for 20 min at 37 ºC. Cells were then permeabilized by  treatment with 
PEMS + 1% Triton X-100 for 30 s, after which they  were recovered in PEMBAL (PEM 
with 1% BSA, 0.1% NaN3, 100 mM  lysine hydrochloride) for incubation with α-HA 
antibody (12CA5, mouse monoclonal) at 1:1000 dilution overnight at room temperature. 
After three washes in PEMBAL, samples were incubated with Alexa 568-conjugated 
anti-mouse secondary antibody  (Invitrogen) at 1:2000 dilution for 3 hours in the dark at 
room temperature. Cells were then washed with PEMBAL and PBS. For imaging, cells 
were stained with 2 µg/mL DAPI to visualize nuclei. Microscopic images were acquired 
in Metamorph (MDS Analytical Technologies) using a 63x objective on an Axioplan 2 
(Carl Zeiss, Inc.) epifluorescence microscope and a CoolSNAP HQ camera (Roper 
Scientific), with the same exposure settings for all images.
Quantitative RT-PCR. Total RNA was extracted using acidic phenol, DNase I-treated, 
and purified with the RNeasy kit (Qiagen). RNA concentration was quantified and its 
integrity  was determined by agarose gel electrophoresis. cDNA was synthesized using 
random hexamers and the SuperScriptIII First Strand Synthesis SuperMix (Invitrogen). 
Relative quantification of cDNA was carried out in triplicate for each independent 
experiment using qPCR MasterMix Plus for SYBR Green (Applied Biosystems) on an 
ABI 7900 Real-Time PCR system. Primers used for quantitative PCR are listed in 
Supplementary  Table 2. Standard curves were generated using least six 2-fold serial 
dilutions of a control sample and values within the linear exponential phase were used to 
calculate relative concentrations after normalization to the endogenous actin controls.
93
Oligonucleotide primers used in quantitative RT-PCR.
Gene ID Left Right
actin SPBC32H8.12c CGAACGTGAAATTGTTCGTG GGAGGAAGATTGAGCAGCAG
mde5 SPAC25H1.09 TTGCCGGACATTGATACAGA CCGTCGATTTTGAACTGCTT
erf2 SPBC3H7.09 CTTTTTGGCTCTGGCATCAT AATTCCTGGATCAGCAGTCG
erf4 SPAC3F10.07c CGCAATATGGGGTTTTTGAG GGCAGAGGGAAGTGTTCGTA
pfa3 SPBC2F12.15c TGCCATCACCAAAACTTTCA TCATTCCAACAGCAAAAGCA
pfa5 SPBC691.01 GGTGATTTACCATGGGATCG GAAGCGGCAAAATCCAATTA
swf1 SPBC13G1.07 TCCATACTCCGCCTTGGTTA CCCAGTTCCCCTTCACTTTT
akr1 SPAC2F7.10 TTAGCCGCTAGTCAGGGAGA AATGCAGTTGCTCCACCTTC
Metabolic labeling and preparation of cell lysates. Cells were labeled with 10 µM  of 
alk-16 (20-50 mM  DMSO stock) for 15 min, washed once with PBS prior to liquid 
nitrogen freezing and storage at -80 °C. For inhibitor experiments, cells were 
preincubated for 30 min with either 200 µ g/mL CHX or 200 µ M 2BP, which were 
maintained in the cultures during alk-16 labeling. Competition experiments were carried 
out with various palmitate concentrations in the cultures during metabolic labeling. To 
prepare cell lysates, Brij lysis buffer (1% (v/v) Brij-97, 150 mM NaCl, 50 mM 
triethanolamine pH 7.4, 5× concentration of Roche EDTA-free protease inhibitor 
cocktail, 10 mM PMSF) and acid-washed glass beads (Sigma) were added to the frozen 
yeast cell pellets, which were lysed (3 x 20 s) using the Fastprep  homogenizer (Thermo 
Scientific) at 4 min intervals to avoid overheating. Lysates were spun at  1,000 g for 5 min 
to remove cellular debris. Typical lysate protein concentrations of 5-10 mg/mL were 
obtained, as quantified using the BCA assay (Pierce).
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Immunoprecipitations and CuAAC. For analyses of whole cell lysates, 50 µg of protein 
was diluted with Brij lysis buffer to a final volume of 44.5 µL, to which 5.5 µL of freshly 
mixed CuAAC reagents were added. The CuAAC reagents consisted of 1 µL az-Rho (5 
mM stock solution in DMSO), 1 µL tris(2-carboxyethyl)phosphine hydrochloride (TCEP) 
(50 mM  freshly prepared stock solution in deionized water), 2.5 µL tris[(1-
benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA) (2 mM stock solution in 1:4 
DMSO:t-butanol) and 1 µL CuSO4·5H2O (50 mM  freshly prepared stock solution in 
deionized water). After 1 hour at room temperature, proteins were methanol-chloroform 
precipitated to remove excess CuAAC reagents. The protein pellets were air-dried and 
resuspended in SDS buffer (4% (w/v) SDS, 150 mM  NaCl, 50 mM triethanolamine pH 
7.4) by sonication before SDS-PAGE. For Ras1 and HA immunoprecipitations, 1-3 mg of 
cell lysate was added to 4 µg anti-Ras antibody (Ras10, Millipore) with 25 µL Protein A 
agarose (Roche) or to 15 µL of anti-HA antibody–conjugated agarose (3F10, Roche) 
respectively. After 2 hours incubation with rocking at  4 °C, the beads were washed three 
times with ice-cold RIPA buffer (1% (v/v) Triton X-100, 1% (w/v) sodium deoxycholate, 
0.1% (w/v) SDS, 50 mM triethanolamine pH 7.4, 150 mM  NaCl). The washed beads 
were resuspended in 20 µL of PBS and 2.25 µL freshly-mixed CuAAC reagents described 
above. The beads were then washed three times with ice-cold RIPA buffer prior to boiling 
in SDS buffer for SDS-PAGE.
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In-gel fluorescence scanning and Western blots. Fluorescence gels were visualized on a 
Typhoon 9400 variable mode imager (GE Healthcare) at excitation 532 nm/emission 580 
nm. For Western blotting, proteins separated by SDS-PAGE were transferred to 
nitrocellulose membranes and probed with the following antibodies: anti-Ras (Ras10, 
Millipore), anti-tubulin (Tat1, gift  from Keith Gull) and anti-HA (3F10, Roche). To avoid 
visualizing the light chain band in anti-Ras1 immunoblots of Ras1 immunopurifications, 
an Fc-specific anti-mouse-HRP secondary antibody (A2544, Sigma) was used. Blots 
were developed using the enhanced chemiluminescence kit  (GE Healthcare). Images 
were processed using Image J.
Affinity enrichment and mass spectrometry. CuAAC reagents (az-azo-biotin) were 
added to 10 mg cell lysate at the same concentrations described above. Proteins were 
methanol-precipitated and resulting air-dried protein pellets were resuspended in 1 mL 
SDS buffer containing 10 mM EDTA by sonication. The mixture was diluted 1:3 with 
Brij lysis buffer and incubated with 100 µL of washed streptavidin agarose resin (Pierce) 
for 1 hour on a nutating mixer at room temperature. The beads were then washed once 
with 0.2% (w/v) SDS in PBS, three times with PBS and twice with 250 mM ammonium 
bicarbonate (ABC). Beads were resuspended in 500 µL 8 M  urea, and reactive cysteines 
were alkylated by addition of 25 µL 200 mM  TCEP and 25 µL 400 mM iodoacetamide 
for 30 min. The beads were washed twice with 50 mM ABC. Two sequential elutions of 
proteins from the resin were performed by incubating the beads with 250 µL of 25 mM 
sodium dithionite in 50 mM  ABC with 0.1% (w/v) SDS for 30 min each. Proteins were 
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concentrated using YM-10 Centricons (Millipore), dried in a speed vac and separated by 
SDS-PAGE. Upon staining with Coomassie blue, each lane was cut into 10 slices for 
trypsin digestion and peptide extraction. Extracted peptides were dried and resuspended 
in 0.1% (v/v) trifluoroacetic acid for mass spectrometry identification. Acquired MS/MS 
spectra were analyzed using the Sequest search engine to identify proteins from the 
primary sequence database obtained from the S. pombe GeneDB. Exported Sequest 
results were analyzed using Scaffold (Proteome Software).
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CHAPTER 4
A FISSION YEAST MODEL FOR PALMITOYLATION-MEDIATED 
REGULATION OF SIGNAL TRANSDUCTION
Introduction
In S. pombe, meiosis is part of a highly coordinated sexual differentiation process that is 
triggered by nutrient depletion. This important switch from the mitotic cell cycle to 
meiosis involves striking changes global gene expression135, 136 and is governed by master 
regulator Mei2, an RNA binding protein (Fig. 4.1a). Mei2 binds to meiRNA, forming a 
dot structure that sequesters Mmi1 and enables stable expression of meiosis-specific 
transcripts critical for meiosis I148. Although the molecular functions of Mei2 in initiating 
and orchestrating the meiotic program are not fully elucidated, it is apparent that Mei2 is 
the master regulator that integrates extracellular cues (stress, nutrients and pheromones), 
primarily  through transcription factor Ste11, and drives the meiosis (Fig. 4.1b). Mei2 
function is tightly regulated by the Pat1 kinase, which phosphorylates and inactivates 
Mei2, preventing meiotic entry during the mitotic cell cycle149. Together, the Pat1-Mei2 
system constitute the core mitosis-meiosis switch in fission yeast. Thermal inactivation of 
Pat1 in cells carrying the temperature sensitive pat1-114 allele or even weak expression 
of a constitutively active Mei2 (Mei2SATA) is sufficient to induce ectopic meiosis and 
sporulation regardless of nutritional cues and ploidy of the cells137-139, 149. Under 
physiological conditions, however, complete inactivation of Pat1 and meiotic induction 
strictly  requires the stoichiometric inhibitor Mei3, which is only expressed in 
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heterozygous diploids formed after successful conjugation150-152. Working in concert, 
these key cellular factors integrate environmental cues and control cellular commitment 
to meiosis.
Figure 4.1 |  Key cellular factors underlying the  mitotic-meiotic decision in S. pombe. a, 
RNA-binding protein Mei2 is a critical regulator of meiotic initiation and progression. A number 
of meiosis-specific transcripts carry DSR (determinant of selective removal) regions, which 
renders them eliminated during the mitotic cell cycle by Mmi1. During meiotic prophase, Mei2, 
together with meiRNA, sequesters Mmi1, so that  meiosis-specific transcripts become free from 
Mmi1-dependent  elimination and be expressed. Adapted from Harigaya et  al.148 b, Key regulators 
integrate different signal transduction pathways (boxes) to regulate the initiation of meiosis. 
Green: positive regulators. Red: negative regulators.
 In the previous chapter, I demonstrated that rheostatic control of Rho3 
palmitoylation by varying levels of the Erf2-Erf4 PAT is a major determinant of meiotic 
commitment in S. pombe. In this chapter, I seek to determine where Erf2-Erf4 fit in the 
regulatory  network of the meiotic program. Epistasis analysis revealed genetic 
interactions between erf2, erf4 and the key regulators of meiotic commitment (Fig. 4.1b) 
as well as the components of the stress-activated protein kinase (SAPK) pathway. 
Consistent with this, various stress response defects were observed for erf2∆ and erf4∆ 
cells, which were associated with changes in global palmitoylation profiles. Taken 
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together, these results, though somewhat preliminary, suggest an intriguing role of the 
Erf2-Erf4 PAT in coordinating cellular response to stress and sexual differentiation. 
Given the homology between components of the S. pombe and mammalian MAPK/
SAPK pathways, if validated, this system offers a powerful tool to study palmitoylation-
mediated regulation of signal transduction for diverse stimuli.
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Results
pat1-114 provides a sensitized genetic background for Erf2-induced meiosis
In normal meiosis, heterozygous diploid zygotes formed after successful conjugation 
express Mei3, which inactivates Pat1 and leads to activation of Ste11 and Mei2, which in 
turn drives meiotic entry  (Fig. 4.2a, box). As described in Chapter 3, overproduction of 
the Erf2-Erf4 PAT is sufficient to trigger a meiotic phenotype in otherwise proliferating 
cells. I further determined that induction of this meiotic phenotype requires canonical 
meiotic regulators, specifically  Ste11 and Mei2, but not Mei3 (Fig. 4.2a). The latter is not 
unexpected since mei3 expression is restricted to heterozygous zygotes whereas Erf2-
Erf4 overproduction is sufficient to induce meiosis in haploid and homozygous diploid 
cells. This also indicates that the Erf2-induced meiotic phenotype is not a result of 
unscheduled mei3 expression. Curiously, a routine control experiment revealed that the 
meiotic phenotype observed with Erf2-Erf4 overproduction is only  apparent in the 
pat1-114 but not pat1+ genetic background (Fig. 4.2b). Since lower Pat1 kinase activity 
has been reported for pat1-114 cells even at permissive temperature153, I hypothesized 
that high Erf2-Erf4 activity induces the meiotic phenotype in these sensitized cells by 
activating the Ste11-Mei2 pathway  or inactivating Pat1 via a Mei3-independent 
mechanism.
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Figure 4.2 | Erf2-Erf4 function in meiotic control  is revealed in pat1-114 cells. DAPI (left) 
and DIC (right) images of haploid cells 96 h after erf2 and erf4 co-overexpression. Cells were 
maintained in the presence of nutrients at  permissive temperature. Scale bars, 10 µm. a, Epistasis 
analysis revealed that  canonical meiotic regulators Ste11 and Mei2, but  not  Mei3, are required for 
Erf2-Erf4 induced meiosis in pat1-114 cells. Cellular factors involved in the S. pombe mitosis-
meiotic switch are indicated in the box. In normal meiosis, Mei3 inactivation of Pat1 leads to 
activation of Ste11 and Mei2, which drives meiotic entry. Activation and inhibition are 
represented by arrows and crossing bars, respectively. b, Erf2-Erf4 induced meiosis is observed in 
pat1-114 but not pat1+ cells.
Erf2-induced meiosis requires the stress-activated protein kinase (SAPK) pathway
To test  this, I determined the epistatic relationship of Erf2-Erf4 overproduction to a 
number of mutants constructed in the pat1-114 genetic background, focusing on the genes 
in major pathways involved in the commitment to sexual differentiation in fission yeast. 
These include the cAMP, the pheromone signaling MAPK and the SAPK pathways (Fig. 
4.3b). Erf2-Erf4 was overproduced in haploid strains with deletions of different 
components in each signaling pathway. Cells lacking components of the nutrient-sensing 
cAMP pathway (rst2) or pheromone signaling pathway (ras1 and spk1) exhibited the 
meiotic phenotype upon Erf2-Erf4 overproduction (Fig. 4.3a). In contrast, deletion of 
kinases in the SAPK pathway, wis1 and sty1, suppressed the meiotic phenotype (Fig. 
4.3a). Deletion of a specific Sty1 effector, atf1, but not other Sty1 substrates (srk1 and 
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smk2), also suppressed the meiotic phenotype (Fig. 4.3a). Given that Atf1 is required for 
ste11 expression, these observations suggest that Erf2-Erf4 induces the meiotic phenotype 
by activating Ste11-Mei2 via the Wis1-Sty1-Atf1 SAPK pathway (Fig. 4.3b). Such 
activation is perhaps sufficient to overcome the Pat1-mediated meiotic repression in 
pat1-114 cells, in which the Pat1 kinase is not fully active even at permissive 
temperature.
 Genetic interactions between erf2, erf4 and core components of the SAPK 
pathway raises the possibility that Erf2-Erf4, in addition to their roles in meiotic 
commitment, may also be important in controlling cellular response to environmental 
stresses (Fig. 4.3b). Interestingly, both Sty1 and Atf1 are involved in both sexual 
differentiation as well as stress response in fission yeast, suggesting coordination between 
both processes154. Is Erf2-Erf4 also involved in general stress response? In the rest of this 
chapter, I present a series of preliminary observations to support  the role of the Erf2-Erf4 
PAT in the stress response pathway.
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Figure 4.3 |  Epistasis analysis reveals that Erf2-induced meiosis  requires the SAPK 
pathway. a, DAPI (left) and DIC (right) images of haploid cells 96 h after erf2  and erf4 co-
overexpression. Cells were maintained in the presence of nutrients at  permissive temperature. 
Scale bars, 10 µm. b, Signaling pathways involved in the commitment to sexual differentiation in 
fission yeast. Red, gene products are required for Erf2-induced meiosis. Blue, gene products are 
not required for Erf2-induced meiosis. Activation and inhibition are represented by arrows and 
crossing bars, respectively.
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erf2∆ cells are inviable at high temperatures
First, erf2∆ and erf4∆ cells are inviable at 36 °C (Fig. 4.4). Notably, no significant growth 
defects was observed at 34 °C, the restrictive temperature for inactivating Pat1 in the 
synchronous meiosis experiments described in the Chapter 3, suggesting that this growth 
defect at high temperatures does not contribute to the meiotic delay of erf2∆ cells. In 
contrast, deletion of the other PATs does not  affect growth at higher temperatures, 
indicating a specific role of the Erf2-Erf4 PAT in maintaining cell viability at elevated 
temperatures.
Figure 4.4 | erf2∆ and erf4∆ cells are temperature 
sensitive. Serial 10-fold dilutions of exponentially 
growing cultures of the indicated strains, normalized 
to the same OD, were spotted on YE4S plates and 
incubated for 4 days at the indicated temperatures. 
The pat1-114 strain was used as a positive control 
for temperature sensitivity. The deletions were made 
in a pat1+ wild type background.
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erf2∆ cells are delayed in G1 arrest during nitrogen starvation
Second, erf2∆ cells are delayed in their nitrogen starvation response. When homothallic 
fission yeast cells are subjected to depravation of a nitrogen source, they arrest at G1 of 
the cell cycle prior to mating and sporulation. Mutants deficient in sty1 or atf1 deficient 
in G1 arrest and sterile154, 155. Compared to wild type cells, erf2∆ cells arrest much less 
efficiently at G1 and arrest in these cells takes a longer time, as observed by the relative 
sizes of the 1C peak 8 h after nitrogen depletion (Fig. 4.5a). This inefficient G1 arrest in 
erf2∆ cells is accompanied by the appearance of misshapened cells with abnormally thick 
septa (Fig. 4.5a).
 To determine whether Erf2 PAT activity has an impact on the global protein 
palmitoylation during nitrogen starvation, I profiled palmitoylated proteins by in-gel 
fluorescence at different times after transfer to a nitrogen-free medium. In wild type cells, 
palmitoylation of at least two distinct substrates between 25-37 kDa was maintained for 
7-8 h after nitrogen removal despite large-scale protein degradation as observed by 
Coomassie staining of the gel (Fig. 4.5b). On the other hand, in erf2∆ cells, 
palmitoylation of these substrates were only sustained for 3-4 h after nitrogen removal 
(Fig. 4.5b). It would be interesting to determine what these Erf2 substrates are and how 
they contribute to G1 arrest in response to nitrogen depletion.
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Figure 4.5 |  erf2∆ cells are defective  in G1 arrest in response  to nitrogen starvation. a, 
Exponentially growing cells were filter-washed and transferred to nitrogen-free medium for the 
indicated times. Right panel: DNA content analysis of indicated cells pre- and 8 h post- nitrogen 
removal. Left panels: DIC images of the indicated cells 8 h after nitrogen removal. Scale bars, 10 
µm. b, Alk-16 fluorescence profiles of palmitoylated substrates of indicated strains at different 




To investigate whether erf2∆ cells can sense nutritional cues, I performed the following 
nutritional shift experiment. It was previously  reported that cells shifted from a good 
nitrogen source (glutamate) to a poor nitrogen source (proline) are advanced into mitosis, 
which is observed as a transient increase in the proportion of dividing cells and a reduced 
cell length at division156. It is evident that erf2∆ cells, like wild type cells, are able to 
sense and respond to the nutritional glutamate-proline downshift by advancing mitotic 
onset, which leads to a peak in the percentage of dividing cells about 1 h after nutritional 
shift and a reduced cell size at  division (Fig. 4.6). These results demonstrate that the 
delay in G1 arrest upon nitrogen starvation in erf2∆ cells was not due to their inability to 
sense nutritional cues.
Figure 4.6 |  erf2∆ cells  respond to nutrient shifts. Exponentially growing cultures in glutamate-
containing medium were shifted to proline-containing medium at t=0 h. At the indicated times 
after the shift, cells were stained with blankophor. The percentage of septated cells (left panel, 
n≥200) and cell length at  division (right  panel, n=20) were determined by counting and 
measuring blankophor-stained cells. Previously reported values for wild type cells and a TOR 
mutant that is unable to respond to nutritional shift  are also included156. Although the trend holds, 
discrepancies between the two studies may be due to different growth temperatures (25 °C vs 32 
°C) and the use of synchronous vs asynchronous cultures.
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erf2∆ cells exhibit morphological defects during recovery from stationary phase
Third, erf2∆ and erf4∆ cells exhibit are defective in growth recovery from stationary 
phase. Upon growth to saturation, fission yeast cells exit the mitotic cycle and enter 
stationary phase, accumulating in G1 or G2 depending on whether they are deprived of 
nitrogen or carbon, respectively157. Because of the growth medium used, when haploid 
cells are grown to high densities, glucose is usually limiting and cells accumulate in 
G2157. When the starved cultures were reinoculated into fresh medium, wild type cells 
exit stationary phase and resume normal cell division (Fig. 4.7a). In contrast, 
morphological defects were observed in erf2∆ and erf4∆ cells after dilution into fresh 
medium. These include the appearance of misshapened and multiseptated cells as well as 
excessive deposition of cell wall material and abnormally thick septa (Fig. 4.7a). The 
heterogeneity of these cells can be observed by the spread of data points on the forward/
side scatter plots compared to wild type (Fig. 4.7d). The failure by the multiseptated cells 
to complete cytokinesis is also reflected in the DNA content analysis, where a 4C peak is 
observed for erf2∆ cells (Fig. 4.7c). Interestingly, this phenotype is transient and resolves 
over time as the cells resume normal growth but can be observed if the culture is again 
starved and refed (Fig. 4.7b), suggesting that these defects in erf2∆ and erf4∆ cells are 
restricted to the initial recovery period from stationary phase.
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Figure 4.7 | erf2∆ cells exhibit morphological  defects  during recovery from starvation at 
high cell  density. Cultures at  OD595 ~3 were incubated at  32 °C for 16 h prior to dilution into 
fresh medium. Indicated times refer to the time after starved cultures were diluted into fresh 
medium. a, DIC images of indicated strains 5.5 h after dilution of starved cultures into fresh 
medium. Scale bars, 10 µm. b, Percentage of cells with defective morphology (misshapened, 
multiseptated, excessive cell wall material) for indicated strains (n=200). #: cultures were grown 
to high density and then rediluted into fresh medium. c, DNA content  analysis of indicated 
strains. d, Forward (FSC) and side (SSC) scatter plots of the indicated strains.
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To determine whether Erf2 PAT activity has an impact on the global protein 
palmitoylation during recovery from stationary phase, I profiled palmitoylated proteins 
by in-gel fluorescence at different time points after dilution of the starved cultures into 
fresh medium. In wild type cells, there is a striking and reproducible increase in protein 
palmitoylation 1 h after refeeding the cultures (Fig. 4.8a). Interestingly, this increase in 
global protein palmitoylation, which is absent in erf2∆ cells (Fig. 4.8a), occurs before the 
appearance of the multiseptated erf2∆ cells as observed by the appearance of the 4C peak 
by flow cytometry  analysis (Fig. 4.8b). It would be interesting to determine how these 
modified substrates contribute to recovery from stationary  phase and if they are the same 
substrates that mediates the nitrogen starvation response.
Figure 4.8 | Different palmitoylation profile of erf2∆ cells during recovery from starvation at 
high cell  density. Cultures at  OD595 ~3 were incubated at  32 °C for 16 h prior to dilution into 
fresh medium. Indicated times refer to the time after starved cultures were diluted into fresh 
medium. a, Alk-16 fluorescence profiles of palmitoylated substrates of indicated strains (top 
panels) and Coomassie staining of the gels (bottom panels). (-): DMSO controls. b, DNA content 
analysis of the indicated strains.
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Summary and Discussion
In this chapter, I showed genetic interactions between erf2, erf4 and important regulators 
of meiotic commitment as well as the components of the SAPK pathway. Together with 
the abnormal stress responses observed in erf2∆ and erf4∆ cells, these preliminary results 
suggest potential role(s) of the Erf2-Erf4 PAT in coordinating cellular response to stress 
and sexual differentiation.  
 In S. pombe, the SAPK pathway mediates a variety of cellular responses to heat, 
oxidative, nutritional, osmotic and UV stresses, controlling the initiation of sexual 
differentiation/mating and stationary  phase survival as well as resistance to drugs and 
heavy  metals. Sty1 is the core MAPK module in the SAPK pathway. Sty1 is activated by 
the Wis1 MAPKK158, 159, which in turn is activated by MAPKKK’s Wis4 and Win1160-164 
(Fig. 4.9a). Atf1 is a target transcription factor downstream of Sty1 and directs stress-
specific gene expression155, 165. Consistent with Sty1 and its targets playing critical roles 
in general stress response, inactivation of sty1 or atf1 results in cells that are 
hypersensitive and fail to respond appropriately to a variety of stresses, including the 
inability to grow at high temperatures, survive stationary phase growth and arrest  cell 
cycle in G1 upon nitrogen depletion154, 155. Similar phenotypes observed in erf2∆ cells 
suggest role(s) for Erf2 and protein palmitoylation in regulating the general stress 
response. This is further suggested by the altered global palmitoylation profiles in erf2∆ 
cells under these conditions. It would be interesting to identify  the Erf2 substrates 
involved in these stress responses and determine how palmitoylation regulates their 
function. Nonetheless, more work will have to be done to validate the function of the 
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Erf2-Erf4 PAT in the general stress response and if it has a direct or indirect regulatory 
role on the SAPK pathway and meiotic commitment (Fig 4.9a).
Figure 4.9 | A fission  yeast model for palmitoylation-mediated regulation of signal 
transduction. a, A model for the role(s) of the Erf2-Erf4 PAT in coordinating cellular response to 
stress and sexual differentiation. Pathways indicated by dashed lines are conceptual and 
speculative. Activation and inhibition are represented by arrows and crossing bars, respectively. 
b, Homology between mammalian and S. pombe SAPK pathways.
113
 Given the homology between components of the S. pombe and mammalian SAPK 
pathways, if validated, the system described above offers a powerful tool to study 
palmitoylation-mediated regulation of signal transduction. Besides structural homology 
between the SAPKs and transcription factors, the SAPK cascades in fission yeast  and 
mammals are similarly regulated and control the activity of transcriptional factors that 
determine biological responses to various stresses (Fig. 4.9b). In mammals, the SAPK 
pathways are activated by environmental stimuli similar to S. pombe and are involved in 
apoptosis, DNA repair, cellular proliferation and differentiation166. Stress signals are 
delivered to the SAPKs by small GTPases of the Ras and Rho (Rac, Rho, Cdc42) 
families, some of which are known to be reversibly palmitoylated11, 167. Ras, for example, 
is proposed to signal through distinct MAPK/SAPK pathways from different membrane 
compartments19, 26, 168, which is in turn regulated by palmitoylation22, 24. Nonetheless, 
evidence for differential signal outputs from each compartment is limited and largely 
confined to overexpression studies of molecules re-targeted to ectopic compartments. 
Therefore, this fission yeast system, in which a specific PAT function is coupled to a 
conserved signaling pathway, provides a tractable model to uncover the role of protein 




Genotype of S. pombe strains used.
Strain Genotype Source
PN1 h- Nurse lab 
PN2283 h- pat1-114 Nurse lab 
Mz53 h- erf2Δ::NatMX6 This study
Mz166 h- erf4Δ::KanMX6 This study
Mz126 h- akr1Δ::KanMX6 This study
Mz120 h- pfa5Δ::KanMX6 This study
Mz254 h- akr1Δ::KanMX6 pfa5Δ::KanMX6 This study
Mz364 h- pfa3Δ::KanMX6 ade6-M216 This study
Mz476 h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 rho3-HA3::KanMX6 This study
Mz518 h- nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 rho3-HA3::KanMX6 This study
Mz531 h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 mei2Δ::natMX6 ura4-D18 This study
Mz626 h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 mei3Δ::ura4+ ura4-D18 This study
Mz630 h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 ste11Δ::ura4+ ura4-D18 This study
Mz632 h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 atf1Δ::ura4
+ 
ura4-D18 This study
Mz564 h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 spk1Δ::ura4
+ 
ura4-D18 This study
Mz551 h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 sty1Δ::ura4
+ 
ura4-D18 This study
Mz571 h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 wis1Δ::ura4
+ 
ura4-D18 This study
Mz624 h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 wis4Δ::ura4
+ 
ura4-D18 This study
Mz644 h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 win1Δ::ura4
+ 
ura4-D18 This study
Mz572 h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 rst2Δ::ura4
+ 
ura4-D18 This study
Mz627 h- pat1-114 nmt1:erf2::KanMX6 nmt1:erf4::KanMX6 srk1Δ::ura4
+ 
ura4-D18 This study




Strain construction and growth conditions. Standard media and methods were used145, 
146. Strains used in this study are listed in Supplementary  Table 1. All experiments were 
carried out in minimal medium (EMM) and minimal medium plus supplements 
(EMM4S) for prototrophic and auxotrophic strains respectively at 32 °C unless otherwise 
noted. When applicable, strains were generated by tetrad dissection and validated by 
marker segregation or PCR. Deletion strains and those expressing erf2 and erf4 from nmt 
promoters were constructed by PCR integration147. 
Epistasis analysis. Cultures were grown to midlog in EMM plus 10 mg/mL thiamine at 
25 °C. erf2 and/or erf4 expression from nmt promoters was induced by  filter-washing the 
cells three times with EMM as described above. The cells were resuspended in EMM and 
growth was maintained at 25 °C since these strains are constructed in a pat1-114 
background. The cultures were diluted with EMM approximately every 12 hours for the 
duration of each experiment to keep OD595 <0.6 and in the presence of nutrients. t=0 is 
defined as the time of thiamine removal. At t=96 h, cells were harvested and ethanol-
fixed prior to DAPI staining and imaging.
Nitrogen starvation. Cultures were grown to midlog in EMM  at  32 °C. Nitrogen was 
removed by filter-washing the cells three times with nitrogen-free EMM (EMM-N) and 
resuspending the cells in EMM-N. Cultures were then returned to 32 °C.
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Glutamate to proline nutritional shift. These experiments were conducted as reported156 
with the exception that the cells were grown at 32 °C rather than 25 °C. Cultures were 
grown to midlog in EMM plus 1 mg/mL glutamate at 32 °C. Nutritional shift to a poorer 
nitrogen source was performed by filter-washing the cells three times with EMM  plus 
1.15 mg/mL proline. The cells were resuspened in EMM+proline and returned to growth 
at 32 °C.
Recovery from high cell density starvation. Starter cultures at OD595 ~3 in EMM  were 
incubated for 16 h at  32 °C prior to dilution into fresh EMM at t=0. Indicated times refer 
to the time after starved cultures were diluted into fresh medium. Most analyses were 
performed at 5.5 h after dilution into fresh medium, when morphological defects were 
observed for a large proportion of erf2Δ cells.
Flow cytometry. DNA content was analyzed by flow cytometry  using ethanol-fixed and 
propidium iodide-stained cells (2 µg/mL propidium iodide in 50 mM sodium citrate) on a 
BD FACS Calibur and analyzed using CellQuest software (BD).
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Cell size measurements and cellular staining. For cell size measurements, live cells 
were stained with Blankophor (MP Biomedicals). For DNA staining, ethanol-fixed cells 
were stained with DAPI. Images were acquired in Metamorph (MDS Analytical 
Technologies) using an Axioplan 2 microscope (Carl Zeiss) and a CoolSNAP HQ camera 
(Roper Scientific). Cell size measurements were obtained using the Pointpicker plug-in of 
Image J (National Institute of Health). 
Metabolic labeling and preparation of cell lysates. Cells were labeled with 10 µM  of 
alk-16 (20-50 mM  DMSO stock) for 15 min, washed once with PBS prior to liquid 
nitrogen freezing and storage at -80 °C. To prepare cell lysates, Brij lysis buffer (1% (v/v) 
Brij-97, 150 mM  NaCl, 50 mM triethanolamine pH 7.4, 5× concentration of Roche 
EDTA-free protease inhibitor cocktail, 10 mM  PMSF) and acid-washed glass beads 
(Sigma) were added to the frozen yeast cell pellets, which were lysed (3 x 20 s) using the 
Fastprep homogenizer (Thermo Scientific) at  4 min intervals to avoid overheating. 
Lysates were spun at 1,000 g for 5 min to remove cellular debris. Typical lysate protein 
concentrations of 5-10 mg/mL were obtained, as quantified using the BCA assay (Pierce).
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CuAAC. For analyses of whole cell lysates, 50 µg of protein was diluted with Brij lysis 
buffer to a final volume of 44.5 µL, to which 5.5 µL of freshly mixed CuAAC reagents 
were added. The CuAAC reagents consisted of 1 µL az-Rho (5 mM  stock solution in 
DMSO), 1 µL tris(2-carboxyethyl)phosphine hydrochloride (TCEP) (50 mM  freshly 
prepared stock solution in deionized water), 2.5 µL tris[(1-benzyl-1H-1,2,3-triazol-4-
yl)methyl]amine (TBTA) (2 mM stock solution in 1:4 DMSO:t-butanol) and 1 µL 
CuSO4·5H2O (50 mM freshly  prepared stock solution in deionized water). After 1 hour at 
room temperature, proteins were methanol-chloroform precipitated to remove excess 
CuAAC reagents. The protein pellets were air-dried and resuspended in SDS buffer (4% 
(w/v) SDS, 150 mM NaCl, 50 mM triethanolamine pH 7.4) by sonication before SDS-
PAGE. 
In-gel fluorescence scanning. Fluorescence gels were visualized on a Typhoon 9400 
variable mode imager (GE Healthcare) at excitation 532 nm/emission 580 nm. After 
fluorescence scanning, gels were stained with Coomassie Blue for determination of 




This thesis describes the development and application of chemical approaches to study 
the function and regulation of protein S-palmitoylation, a uniquely reversible lipid 
modification that primarily  serves as an important membrane targeting mechanisms in 
eukaryotes. Using fatty acid chemical reporters, combined with bioorthogonal labeling 
conditions involving CuI-catalyzed azide-alkyne cycloaddition, I was able to specifically 
and robustly detect lipid modified proteins by fluorescence. I further extended this 
method to allow fluorescent detection of two distinct protein modifications on proteins of 
interest and showed that this tandem imaging method can be used to efficiently monitor 
dynamic palmitoylation in cells. These protocols are currently used by  most members of 
the lab on a routine basis as well as by multiple labs that we have collaborated with for 
studying various protein modifications. Combining chemical and genetic approaches in 
fission yeast, I showed that quantitative control of an acyltransferase complex during 
meiosis results in differential activity on cognate substrates and shaping of the 
palmitoylome, which is an important determinant for commitment to this major 
transitional event in S. pombe. Based on this study, I propose that rheostatic control of 
acyltransferase activity  provides an important mechanism for regulating global protein 
palmitoylation and that this may have significant impacts on major developmental 
transitions.
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Fission yeast is a relevant and complementary model for palmitoylation studies
The genetically amendable fission yeast S. pombe, combined with the use of chemical 
strategies that we have developed, is a relevant and complementary model for 
understanding basic control mechanisms and function of protein palmitoylation. Its 
simple PAT network facilitates dissection of the regulation and functional contribution of 
individual PATs. Interestingly, Swf1 is required for cell viability134, and if validated to be 
a bona fide PAT, would be the first  report of an essential DHHC-PAT. Initial efforts to 
make a conditional mutant by replacing the endogenous swf1 promoter with thiamine-
repressible nmt promoters failed, suggesting that regulated swf1 expression is perhaps key 
to its function in maintaining cellular viability. Why is swf1 essential? In budding yeast, 
SWF1 palmitoylates SNAREs required for membrane fusion12, 45 and by homology, the 
putative SNARE substrates of Swf1 in fission yeast, Psy1 and Syb1 , are essential for cell 
viability134, 169, 170. Hence, it  is likely Swf1 mediates essential cellular processes such as 
membrane trafficking and fusion. It will be interesting to study the function of Swf1 by 
means of temperature-sensitive or conditional switch-off alleles.
 Although this thesis focuses on the palmitoylating machinery, some of the 
preliminary experiments that I have conducted indicates that S. pombe would also be a 
good system to study the depalmitoylation machinery. The fact that palmitate turns over 
faster on Ras1 than the protein argues for the existence of protein thioesterase(s). 
Disruption of the only  Apt1 thioesterase homolog in fission yeast did not affect cell 
viability, cell growth at high temperature and stationary phase, mating efficiency, steady 
state Ras1 palmitoylation or global protein palmitoylation by in-gel fluorescence. It 
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remains to be determined if the palmitate half-lives of Ras1 and other palmitoylated 
substrates are different in wild type and apt1∆ cells. As discussed in Chapter 1, it is still 
unclear if APT1 and related isoforms are the main depalmitoylating enzymes or if there 
are potentially  more enzymes to be uncovered. By homology  to APT1 and inhibitor 
studies14, 52, 84, it is likely that depalmitoylating enzymes are serine thioesterases. Given 
that there are hundreds of serine/cysteine hydrolases encoded in the mammalian genome, 
it is more practical to systematically  screen candidate enzymes for the ability to 
depalmitoylate proteins in fission yeast.
PAT levels matter: shaping palmitoylomes by rheostatic control of PAT activity
Evidence for regulation of palmitoylating and depalmitoylating enzymes are limited and 
although individual PATs and APT1 have multiple substrates12,  65,  77,  82, studies tend to 
focus on a single enzyme:substrate pair. For example, It would be interesting to 
determine if the activity-sensitive translocation of DHHC2 affects palmitoylation of other 
neuronal substrates besides PSD95 and if that  contributes to modulation of synaptic 
activity51. Our study in fission yeast, where we identified and monitored three cognate 
Erf2-Erf4 substrates in vegetative and meiotic cells, offers a different perspective. We 
showed that physiological control of Erf2-Erf4 activity  levels underlie the differential 
modification of its cognate substrates in distinct cellular states, suggesting that  rheostatic 
control of single or multiple PAT activities is a basic mechanism by which cells shape 
their palmitoylomes. It raises the possibility  that a single PAT can have different functions 
and regulate different cellular processes depending on its levels. We further showed that 
PAT level-dependent changes in palmitoylomes are important for cellular events such as 
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meiotic commitment in fission yeast. This highlights the importance of studying PATs 
and palmitoylomes in physiologically relevant contexts and provides a possible 
explanation for the extensive biochemical and functional overlap  between the PATs in 
cellular studies involving non-physiological enzyme and substrate concentrations68, 69.
Because of technical difficulties, it remains to be determined how levels of a PAT 
affect its substrate specificity. As previously  discussed, one possibility is a difference in 
“specificity constant” (kcat/KM) and this is supported by the discovery of specificity 
determinants on both the PATs and their substrates that dictate enzyme-substrate 
interactions66, 67. If this were the case, one would predict higher kcat/KM for substrates that 
require lower PAT levels for effective palmitoylation and vice versa. I am currently 
investigating the possibility  of recognition domains on the substrates by first swapping 
Rho3 and Ras1 palmitoylation motifs and asking if this affects the PAT level-dependence 
of each substrate. Another possibility is that depalmitoylating thioesterases or competing 
cellular factors target certain substrates more efficiently40, 84, 86, 87. This can be addressed 
by comparing the palmitate turnover on the different Erf2 substrates. Alternatively, level-
dependent changes in PAT localization might alter substrate availability. For example, 
DHHC2 translocates to post-synaptic membranes upon neuronal stimulation and 
mediates increased palmitoylation and synaptic targeting of PSD9551, implicating PAT 
compartmentalization as a means to control activity-induced palmitoylomes. In our study, 
however, subcellular localization is unlikely to account for the difference in Ras1 and 
Rho3 palmitoylation since both proteins are localized to the same compartments in 
vegetative cells28, 144. These proposed mechanisms are not mutually exclusive since 
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mobilization of PATs might be interpreted as an increase in local PAT concentration, 
which might then increase protein palmitoylation by mass action or by titration of 
competing cellular factors. 
Conservation of specific PAT:substrate pairs
I showed that the Erf2 PAT in fission yeast, can have different substrate preferences and 
that specific PAT-substrate pairs are needed for efficient palmitate transfer, which is 
consistent with studies in mammals and budding yeast12, 65. Notably, the Erf2-Erf4:Ras1 
PAT:substrate pairing in fission yeast is reminiscent of the ERF2-ERF4:RAS1/RAS2 and 
DHHC9-GCP16:H-/N-Ras pairs in budding yeast and human, respectively58, 59. Given 
that humans and yeast diverged about 1 billion years ago while S. pombe and S. cerevisae 
diverged 300-400 million years ago, this suggests an evolutionary  selection for specific 
cognate PAT:substrate pairs, which would be unlikely if PATs have extensive overlapping 
substrate preferences and were able to freely  substitute for each other. Interestingly, the 
Erf2-Erf4:Rho3 pair in fission yeast is also found in budding yeast12, raising the 
possibility that DHHC9-GCP16 might also modify Rho GTPases in mammals. This is 
further suggested by  the large number of mammalian Rho GTPases with cysteines close 
to the N- or C- terminus, which serve as potential palmitoylation sites (Fig. 5.1). If 
DHHC9-GCP16 indeed does palmitoylate Rho proteins, it would be interesting to 
determine if, like Erf2-Erf4, it can differentially modify Ras and Rho proteins.
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Figure 5.1 |  Mammalian Rho GTPases. An unrooted phylogentic tree that is based on the 
ClustlW alignment of the amino-acid sequences of the 20 Rho GTPase proteins. The tree 
demonstrates the relationship between the different  family members. EMBOSS pairwise 
alignment was used to calculate the percentage of amino-acid-sequence identity within 
subfamilies. High sequence similarity is found between proteins within the Rac and Rho 
subfamilies, whereas the other subfamilies are much less similar. Adapted from Heasman et al.171
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Role of protein palmitoylation in other developmental transitions
The highly conserved Ras and Rho GTPases are essential for cellular differentiation and 
development in mammals171. Conservation of PAT function and specific PAT:substrate 
pairs between yeasts and humans suggests regulatory roles of palmitoylation in major 
developmental transitions in metazoa. This is supported by  expression profiling 
experiments in flies and humans in which transcript levels of specific PATs vary widely 
across tissues70, 71. Neuronal differentiation signals were found to induce the PAT 
degradation via the ubiquitin-proteosome pathway74. In addition, PAT mutation and 
misregulation is associated with a variety  of developmental defects as well as cancers in 
humans (summarized in Table 1.2). It will be interesting to determine if the control of 
PAT levels and regulation of palmitoylomes are important for cellular development and 
disease.
Rho3 coordinates regulation of membrane trafficking and polarized exocytosis
We demonstrated that  both the actin nucleating formin For3 and exocyst subunit  Exo70, 
but not the clathrin-adaptor Apm1, is required for the essential role of Rho3 in Erf2-
induced meiosis. A recent study proposed that polarized exocytosis in fission yeast, rather 
than being a linear event of actin-dependent long-range vesicle transport followed by 
exocyst-dependent vesicle tethering at the PM172, can be independently  mediated by 
either pathway173. Physical and/or genetic interactions between Rho3 and For3 as well as 
different subunits of the exocyst complex indicates that Rho3 regulates and potentially 
coordinates these actin-dependent  and exocyst-dependent secretory pathways143,  144 (Fig. 
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5.2a). Interestingly, Rho3 is localized to the cell periphery as well as endomembranes 
(Golgi/endosome), raising the possibility  that Rho3 signaling, like Ras1, may be 
compartmentalized. This is supported by  studies showing that Rho3 colocalizes with For3 
at the cell periphery143,  144 and with Apm1 at endomembranes174. Physical interactions 
between Rho3 and For3 as well as Apm1 were validated biochemically144,  174. Spatial 
compartmentalization may explain how Rho3 can control multiple pathways including 
golgi/endosome trafficking, cytoskeletal organization and polarized exocytosis143,  144, 174 
(Fig. 5.2b). This can be tested by  artificially targeting Rho3 to different compartments 
and measuring signaling outputs from each pathway biochemically and phenotypically.
 How does Rho3 palmitoylation regulate meiotic commitment? If the 
compartmentalized signaling model is correct, one would expect factors that regulate the 
cellular distribution of Rho3 to affect its function. These factors include Cdc42 and 
exocyst localization143,  144 and, as shown here, Erf2-mediated palmitoylation. I am 
currently constructing strains that express palmitoylation-deficient Rho3 to confirm this. 
The role of Rho3 palmitoylation may  then be tested by looking at trafficking of known 
cycling substrates (e.g. vesicular SNAREs), secretion of acid phosphatase as well as 
endocytosis and vacuole sizes (FM4-64, membrane markers) in cells expressing wild type 
and palmitoylation-deficient Rho3. Delivery of cytoplasmic vesicles to discrete plasma-
membrane domains is critical for establishing and maintaining cell polarity, neurite 
differentiation and regulated exocytosis. Anastasia and co-workers showed that blocking 
membrane traffic causes a mitotic checkpoint, suggesting a link between mitotic entry 
and membrane growth in budding yeast175. If Rho3 palmitoylation affects membrane 
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trafficking, signals that are coupled to membrane growth may explain how Rho3 
regulates meiotic entry in fission yeast. These signals may be increased concentration of 
receptors and effectors at the plasma membrane or simply non-specific stress signaling as 
a result of defective membrane trafficking or cytoskeleton organization. The identity  of 
these signals are unknown (Fig. 5.2b).
Figure 5.2 | Model  for coordination of membrane  trafficking and polarized exocytosis by 
Rho3 in S. pombe. a, Rho3 may coordinate parallel actin-dependent and exocyst-dependent 
secretory pathways. Cdc42 sets up cell polarity and regulates two parallel morphogenetic 
modules for polarized cell growth, the formin-dependent actin cable module and the exocyst 
module, contributing to transport  and tethering of exocytic vesicles, respectively. The exocyst is 
also controlled by PIP2 levels at the plasma membrane. Actin patches, and thus endocytosis, may 
contribute to maintaining polarized localization of Cdc42 and the exocyst. An effector of Rho3, 
For3 binds to both active forms of Cdc42 and Rho3. Rho3 localization is dependent  on the 
exocyst  but  not vice versa. b, Speculative model of compartmentalized Rho3 signaling. # depicts 
the different  factors such as cytoskeleton, exocyst  function and palmitoylation may affect Rho3 
distribution, which in turn affect its function by signaling though different  effectors. How these 




Although I chose to focus on meiosis for my  thesis, Erf2-Erf4 function is implicated in 
multiple cellular processes including stress response, mating, meiosis and sporulation. 
This raises an important question - how does a single PAT selectively control and 
coordinate these different pathways? This may be achieved via different substrates and 
we showed here that substrates of the same PAT can be differentially  modified simply  by 
changing PAT activity levels. It will be worthwhile to catalog the different Erf2 substrates 
that are modified during each of the cellular events and determine if their palmitoylation 
states affect coordination of these temporally  separated processes: stress response ➔ 
mating ➔ meiosis ➔ sporulation.
 As shown by others and in our study, palmitoylation is not an all-or-nothing 
process and the steady state palmitoylation levels of a specific substrate can vary  over a 
large range. While I have focused on the high and low palmitoylation levels of Rho3 in 
meiotic and vegetative cells respectively, it remains to be seen if intermediate Rho3 
palmitoylation has a function in the different cellular processes. In the case of PSD95, 
whose palmitoylation has been shown to affect  synaptic clustering and signaling 
strength39, 51,  176‐178, one expects a positive correlation between synaptic strength and the 
levels of steady state PSD95 palmitoylation.
Model organisms and technical advances are important for new discoveries
Technical difficulties in palmitoyl enzymology and detection/analysis hindered 
palmitoylation studies for more than 30 years since the initial discovery of the 
129
modification179. In the last  decade, the use of model organisms and technical advances in 
the detection and analysis of palmitoylation have propelled this emerging field (Fig. 5.1). 
 Yeast genetics have proven fruitful in landmark discovery  of the PATs as the main 
palmitoylating enzymes57, 58, 63 when biochemical attempts to purify them were 
complicated by the instability  of these enzymes once they  are extracted from 
membranes180, 181. The budding yeast model has been and continues to be instrumental in 
our understanding of PAT specificity12, 66, 69 and mechanism of palmitate transfer61, 62.
 The advent of the acyl-biotin exchange protocol as well as bioorthogonal 
chemical reporters described in this thesis enabled identification of palmitoylomes, 
greatly expanding the scope of the modification and providing unprecedented insights 
into the cellular function of palmitoylation. Furthermore, these two approaches allowed 
robust non-radioactive detection of palmitoylated proteins expressed at endogenous 
levels, reducing experimental times and enabling faster testing of hypotheses.
 Advanced microscopy techniques, in combination with semi-synthetic 
lipopeptides, offer unprecedented insights into the dynamics of protein palmitoylation. 
Photo-activation/bleaching of fluorescent palmitoylated proteins estimate protein-bound 
palmitate to turnover in milliseconds or seconds22, 24, which is consistent with rapid 
physiological responses that can occur on the seconds time scale. This is in contrast to 
biochemical pulse-chase experiments, which yield palmitate half-life measurements in 
the order of minutes or hours potentially due to rapid recycling of the labeled fatty acid 
analogs. Use of semi-synthetic proteins irreversibly linked to palmitate definitively 
showed the importance of the reversibility  of the modification and how palmitate cycling 
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contributes to cellular distribution of modified proteins22. More recently, the design of a 
specific APT inhibitor, Palmostatin B83, 84, potentially allows rapid temporal control of 
depalmitoylation activity and further dissection of the palmitoylation kinetics in cells.
 Together, these technical advances are beginning to reveal mechanistic and 
functional insights into the effect dynamic palmitoylation exerts on physiology and 
disease but tool development will continue to be critical for progress in the field. For 
example, there is still a need for specific PAT inhibitors since most existing 
palmitoylation inhibitors such as 2-bromopalmitate have pleiotropic effects on lipid 
metabolism128. On a similar note, development of activity-based probes that selectively 
react with active PATs or thioesterases will not only allow one to profile the functional 
states of these enzymes in normal and disease models (Fig. 5.3a), but also aid in the 
development of specific inhibitors. In addition, solving the structures of PATs will 
invaluable towards understanding the mechanism of palmitate transfer to substrates and 
origin of substrate selectivity  as well as greatly facilitate the design of selective activity-
based probes and inhibitors. Understanding what dictates enzyme:substrate specificity 
will further help development of approaches that allows control of the palmitoylation 
state of specific proteins of interest. For instance, one can imagine engineering specificity 
determinants that can be appended onto a PAT and a protein of interest such that the 
latter will only  be modified when this orthogonal PAT is expressed. Last  but not least, 
given the evidence for interactions between different PTMs, palmitoylation should not be 
studied in isolation but in conjunction with other modifications, especially 
phosphorylation and other cysteine modifications.
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Figure 5.3 | Activity-based probes for palmitoylation studies. Activity-based probes (selective 
chemically reactive group with a detection/affinity handle) that  specifically react  with active PATs 
or thioesterases enable the profiling of functional states of the enzymes in normal and disease 
models. Figure adapted from the Cravatt lab (Scripps) website.
Concluding remarks
In conclusion, we have developed chemical strategies to efficiently detect and identify 
palmitoylated proteins in mammalian systems and by applying them in an alternative S. 
pombe model, uncovered a mechanism by which PATs regulate global protein 
palmitoylation as well as important cellular events such as meiosis. Our study  also 
highlights the importance of studying the regulation and function of protein 
palmitoylation in physiologically relevant contexts. This is perhaps best demonstrated by 
a series of studies in neurons, which collectively showed that neuronal activity-driven 
regulation of PAT localization and protein nitrosylation modulates protein palmitoylation, 
which in turn modulates neuronal morphogenesis, receptor clustering and synaptic 
strength39, 40, 51, 65, 177, 178. In this thesis, we introduced a genetically tractable system with 
relatively simple enzymatic machinery  and substrate “catalog” that  is valuable towards 
understanding basic principles and control mechanisms of protein palmitoylation in a 
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physiological context. This work exemplifies how chemical strategies may be used in the 
fission yeast system to study the PAT-mediated regulation of palmitoylation and the 
associated effects on cellular physiology. In the process, new questions about multiple 
PAT functions, differential substrate specificity and potential regulatory  roles of 
palmitoylation are generated, which can be systematically tested using this system. The 
next few years represent a challenging and exciting time that promises to reveal 
fundamental insights into protein palmitoylation, which one hopes may one day lead to 
novel therapeutic strategies to control diverse physiological processes.
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APPENDIX 1 - Proteomics data (Pages 134-146)









DMSO alk-16 DMSO alk-16 Net counts DMSO alk-16
Isp3 SPAC1F8.05 20 3 2 30 99 69 8 4
P-type ATPase SPAC6C3.06c 117 0 7 0 14 14 9 9
Vps13b SPBC16C6.02c 339 4 3 0 11 11 4 4
Rho3 SPAC23C4.08 23 0 2 0 11 11 0 0
Sir2 SPBC16D10.07c 53 4 7 0 8 8 0 0
Noc1 SPAC4F10.09c 98 2 4 0 8 8 0 3
Rad24 SPAC8E11.02c 30 7 10 0 6 6 0 3
Cid11 SPBC1685.06 55 4 6 0 6 6 0 0
Dcr1 SPCC188.13c 158 3 0 0 6 6 0 3
Pre5 SPAC6G10.04c 30 0 0 0 6 6 0 0
Gpd1 SPBC215.05 42 0 2 0 6 6 2 3
Hxk1 SPAC24H6.04 54 0 2 0 6 6 0 2
Sak1 SPAC3G9.14 86 3 0 0 5 5 0 2
Ferric-chelate 
reductase SPBC947.05c 65 2 2 0 5 5 2 2
Ucp8 SPBC83.01 98 0 0 0 5 5 0 0
Mss1 SPAC222.05c 55 0 0 0 5 5 0 0
Pli1 SPAC1687.05 81 0 0 0 5 5 0 0
Non classical export 
pathway protein SPBC1685.13 20 0 0 0 5 5 0 0
Top1 SPBC1703.14c 94 0 0 0 5 5 0 2
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SPACUNK4.16c 107 0 0 0 5 5 0 2
UPF0061 family 
protein SPAC20G4.05c 64 0 0 0 5 5 0 2
Nep1 SPBC17D11.01 47 0 2 0 5 5 0 0
Adf1 SPAC20G4.06c 16 0 2 0 5 5 0 0
Trk1 SPAC3F10.02c 96 0 4 4 9 5 2 0
Rpl14 SPAC1805.13 15 9 16 0 4 4 0 0
Uso1 SPAC29E6.03c 122 4 6 0 4 4 0 0
Oxa101 SPAC9G1.04 42 3 0 0 4 4 0 2
Spt8 SPBC14C8.17c 58 3 2 0 4 4 0 0
Hrp3 SPAC3G6.01 159 3 4 0 4 4 4 6
Cytoskeletal protein 
binding protein Sla1 
family
SPAC16E8.01 155 2 0 0 4 4 0 0
Membrane 
transporter SPAC3H1.06c 64 2 0 0 4 4 0 0
Ptc4 SPAC4A8.03c 44 2 2 0 4 4 0 0
Rhp54 SPAC15A10.03c 97 2 2 0 4 4 0 2
Rpl22 SPAC11E3.15 13 2 2 0 4 4 0 2
NAD/NADH kinase SPAC3H5.11 45 2 3 0 4 4 2 3
Sir1 SPAC10F6.01c 164 2 3 0 4 4 0 0
Vps4 SPAC2G11.06 48 0 0 0 4 4 2 0
Klp8 SPAC144.14 57 0 0 0 4 4 2 0
Coq3 SPCC162.05 30 0 0 0 4 4 2 0
Lhs1 SPAC1F5.06 95 0 0 0 4 4 2 2
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Rsc7 SPCC1281.05 44 0 0 0 4 4 0 0
cdc23 SPBC1347.10 67 0 0 0 4 4 0 0
DuF1740 family 
protein SPBC20F10.05 113 0 0 0 4 4 0 0
Conserved fungal 
protein SPCPB16A4.02c 38 0 0 0 4 4 0 0
Grx3 SPCC1450.06c 18 0 0 0 4 4 0 0
Suc22 SPBC25D12.04 45 0 0 0 4 4 0 0
Ght5 SPCC1235.14 60 0 0 0 4 4 0 0
FAD-dependent 
amino acid oxidase SPAC6G10.06 42 0 0 0 4 4 0 0
Rrp6 SPAC1F3.01 90 0 0 0 4 4 0 0
Htb1 SPCC622.09 14 0 0 0 4 4 0 0
zf-CCHC type zinc 
finger protein SPAC683.02c 25 0 0 0 4 4 0 0




SPAC1F5.10 45 0 0 0 4 4 0 0
Rds1 SPAC343.12 44 0 0 0 4 4 0 0
Shf1 SPAC22F8.12c 19 0 0 0 4 4 0 2
Aif1 SPAC26F1.14c 62 0 0 0 4 4 0 2
Ppp1 SPBC19F5.05c 69 0 0 0 4 4 0 2
Mrpl32 SPBC1604.13c 12 0 0 0 4 4 0 2
Rpn2 SPBC17D11.07c 107 0 2 0 4 4 4 2
Ubp22 SPCC188.08c 129 0 2 0 4 4 4 3
Pga2 SPBC27.01c 16 0 2 0 4 4 3 2
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Arh1 SPBC3B8.01c 53 0 2 0 4 4 3 3
Spt5 SPAC23C4.19 109 0 2 0 4 4 2 0
Conserved eukaryotic 
protein SPAC1687.04 57 0 2 0 4 4 0 0
Sequence orphan SPBC405.02c 50 0 2 0 4 4 0 0




SPAC1399.05c 61 3 3 0 3 3 0 0
RNA binding protein SPAC4G8.03c 88 2 2 0 3 3 0 0
Dbp9 SPCC1494.06c 67 2 2 0 3 3 0 0
guanyl-nucleotide 
exchange factor SPAC11E3.11c 106 0 0 0 3 3 3 3
Mcm3 SPCC1682.02c 97 0 0 0 3 3 3 4
Pig-F SPCC1450.15 57 0 0 0 3 3 2 2
Ubiquitin-protein 
ligase E3 SPBC947.10 77 0 0 0 3 3 2 2
Yop1 SPCC830.08c 21 0 0 0 3 3 2 2
Sequence orphan SPAC821.03c 54 0 0 0 3 3 2 3
Sequence orphan SPAC13G7.09c 16 0 0 0 3 3 0 0
AAA family ATPase, 
unknown biological 
role
SPBC947.01 72 0 0 0 3 3 0 0
Sec6 SPCC1235.10c 83 0 0 0 3 3 0 0
Ulp1 SPBC19G7.09 65 0 0 0 3 3 0 0
Apl4 SPCP1E11.06 96 0 0 0 3 3 0 0
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D123 family SPAP27G11.03 37 0 0 0 3 3 0 0
Hst4 SPAC1783.04c 47 0 0 0 3 3 0 0




SPAC17A2.14 71 0 0 0 3 3 0 0
Aspartate kinase SPBC19F5.04 57 0 0 0 3 3 0 0
Fumarate lyase 
superfamily SPBC8E4.05c 50 0 0 0 3 3 0 0




SPAC1093.04c 58 0 0 0 3 3 0 0
WD repeat protein, 
human WDR55 
family
SPAC1A6.02 40 0 0 0 3 3 0 0
Biotin-protein ligase SPBC30D10.07c 71 0 0 0 3 3 0 0
Transcription factor SPBC19C7.10 48 0 0 0 3 3 0 0
Ctf1 SPBC3B9.11c 40 0 0 0 3 3 0 0
Sec15 SPCC1183.01 91 0 0 0 3 3 0 0
Nak1 SPBC17F3.02 71 0 0 0 3 3 0 0
Rpt6 SPBC23G7.12c 45 0 0 0 3 3 0 0
Nucleoporin 
Nup157/170 SPAC890.06 148 0 0 0 3 3 0 0
Mitochondrial citrate 
transporter SPAC19G12.05 32 0 0 0 3 3 0 0
Amidase SPAC869.01 65 0 0 0 3 3 0 0
Uve1 SPBC19C7.09c 69 0 0 0 3 3 0 0
Leu3 SPBC3E7.16c 64 0 0 0 3 3 0 0
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Adaptin SPAC1F3.05 57 0 0 0 3 3 0 0
Ubp6 SPAC6G9.08 52 0 0 0 3 3 0 0
ZIP zinc transporter 1 SPAP8A3.03 50 0 0 0 3 3 0 0
Taf1 SPAC1002.04c 23 0 0 0 3 3 0 0
Phx1 SPAC32A11.03c 104 0 0 0 3 3 0 0
Pex7 SPAC17D4.01 35 0 0 0 3 3 0 0
Gln1 SPAC23H4.06 40 0 0 0 3 3 0 0
Ptr6 SPAC13F5.02c 45 0 0 0 3 3 0 0
Ubi1 SPAC11G7.04 15 0 0 0 3 3 0 0
Las1-like protein SPBC16C6.12c 54 0 0 0 3 3 0 0
Gpi18 SPAC18B11.05 49 0 0 0 3 3 0 0
AMP-activated 
protein kinase beta 
subunit
SPCC1919.03c 33 0 0 0 3 3 0 0
Cbs2 SPAC1556.08c 37 0 0 0 3 3 0 0
Sdh3 SPCC330.12c 20 0 0 0 3 3 0 0
DUF726 family 
protein SPAC607.08c 64 0 0 3 6 3 0 3
Sti1 SPCC645.14c 66 0 2 2 5 3 3 3
Pmc2 SPAC2F7.04 51 3 4 0 2 2 0 0
Rps21 SPBC18E5.06 10 3 5 0 2 2 0 0
Lsk1 SPAC2F3.15 67 2 2 0 2 2 0 0
Swi2 SPAC1142.03c 82 2 2 0 2 2 0 0
Dbp3 SPBC17D1.06 64 2 2 0 2 2 0 0
PQ loop protein SPAC2E12.03c 32 2 3 0 2 2 3 5
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Ypt3 SPAC18G6.03 24 2 3 0 2 2 0 0
TRP-like ion channel SPCC663.14c 77 0 0 0 2 2 2 2
Irs1 SPBC8D2.06 123 0 0 0 2 2 2 3
Lsd90 SPBC16E9.16c 82 0 0 0 2 2 2 3
Pdt1 SPAC27F1.08 58 0 0 0 2 2 2 3
alpha-1,2-
mannosyltransferase SPBC16H5.09c 44 0 0 0 2 2 2 3
Rec11 SPCC4E9.01c 107 0 0 0 2 2 0 0
Conserved fungal 
protein SPCC1494.08c 31 0 0 0 2 2 0 0
Nat10 SPAC20G8.09c 116 0 0 0 2 2 0 0
Abp2 SPBC1861.02 60 0 0 0 2 2 0 0




SPAC27F1.05c 53 0 0 0 2 2 0 0
Mfh1 SPAC9.05 97 0 0 0 2 2 0 0
Conserved fungal 
protein SPAC2F3.14c 38 0 0 0 2 2 0 0
Glc9 SPAC17A5.09c 35 0 0 0 2 2 0 0
Sequence orphan SPBC2G2.14 60 0 0 0 2 2 0 0
Atp23 SPCC320.12 22 0 0 0 2 2 0 0
Spermidine family 
transporter SPBC36.03c 59 0 0 0 2 2 0 0
Mug100 SPBC16E9.07 36 0 0 0 2 2 0 0
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protein SPAC1952.06c 65 0 0 0 2 2 0 0
Ltv1 SPAC3F10.17 44 0 0 0 2 2 0 0
Arg7 SPBC1773.14 52 0 0 0 2 2 0 0
Cmk1 SPACUNK12.02c 38 0 0 0 2 2 0 0
Mitochondrial tRNA SPAC12B10.08c 52 0 0 0 2 2 0 0
Ran GTP-binding 
protein SPAC31A2.10 51 0 0 0 2 2 0 0
Acetyl-CoA 
hydrolase SPAC1952.09c 58 0 0 0 2 2 0 0
C2 domain protein SPCC962.01 156 0 0 0 2 2 0 0
Transcription factor SPAC105.03c 81 0 0 0 2 2 0 0
Arrestin/ PY protein 
1 SPAC31A2.12 66 0 0 0 2 2 0 0
Tht1 SPAC13C5.03 63 0 0 0 2 2 0 0
Sbh1 SPBC2G2.03c 10 0 0 0 2 2 0 0
Nap1 SPCC364.06 44 0 0 0 2 2 0 0
Sequence orphan SPAC7D4.13c 36 0 0 0 2 2 0 0
Ark1 SPCC320.13c 41 0 0 0 2 2 0 0
Svf1 SPCC584.11c 43 0 0 0 2 2 0 0
LEA domain protein SPAC23C4.05c 50 0 0 0 2 2 0 0
Short chain 
dehydrogenase SPAC19A8.06 45 0 0 0 2 2 0 0
TLDc domain protein 
2 SPBC21.02 59 0 0 0 2 2 0 0
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SPAC1296.06 64 0 0 0 2 2 0 0
Gma12 SPCC736.04c 43 0 0 0 2 2 0 0
Rsv2 SPBC1105.14 69 0 0 0 2 2 0 0
Pgp1 SPCC1259.10 46 0 0 0 2 2 0 0
Mep33 SPBC28F2.02 33 0 0 0 2 2 0 0
Rft1 SPBC887.19 60 0 0 0 2 2 0 0
Mitochondrial m-
AAA protease SPBC543.09 85 0 0 0 2 2 0 0
Hta2 SPAC19G12.06c 14 0 0 0 2 2 0 0
Rae1 SPBC16A3.05c 39 0 0 0 2 2 0 0
Hhp1 SPBC3H7.15 42 0 0 0 2 2 0 0
Wee1 SPCC18B5.03 96 0 0 0 2 2 0 0
Pfs2 SPAC12G12.14c 58 0 0 0 2 2 0 0
Cytoskeletal 
signaling protein SPAC637.13c 56 0 0 0 2 2 0 0
Mcp2 SPCC1682.08c 79 0 0 0 2 2 0 0
Mug73 SPCC31H12.02c 35 0 0 0 2 2 0 0
Mbx1 SPBC19G7.06 51 0 0 0 2 2 0 0
Apc11 SPAC343.03 11 0 0 0 2 2 0 0
Nudix family 
hydrolase SPAC14C4.10c 38 0 0 0 2 2 0 0
DUF544 family 
protein SPAC12G12.11c 42 0 0 0 2 2 0 0
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Ppk29 SPBC557.04 96 0 0 0 2 2 0 0
Rfc2 SPAC23D3.02 38 0 0 0 2 2 0 0
Sgf29 SPBC1921.07c 28 0 0 0 2 2 0 0
Nicotinic acid plasma 
membrane transporter SPAC1002.16c 55 0 0 0 2 2 0 0
Peptidase SPCC1259.02c 92 0 0 0 2 2 0 0
Steriod 
dehydrogenase SPAC7D4.09c 32 0 0 0 2 2 0 0
Rhp18 SPBC1734.06 43 0 0 0 2 2 0 0
Membrane 
transporter SPCC965.13 60 0 0 0 2 2 0 0
RINT1 family protein SPBC691.02c 79 0 0 0 2 2 0 0
Rad17 SPAC14C4.13 69 0 0 0 2 2 0 0
Ura3 SPAC57A10.12c 48 0 0 0 2 2 0 0
Fun1 SPCC18.18c 56 0 0 0 2 2 0 0
Erv41 SPBC2G5.04c 38 0 0 0 2 2 0 0
Sce3 SPBC18H10.04c 43 0 0 0 2 2 0 0
IMP 5'-nucleotidase SPBC30D10.03c 46 0 0 0 2 2 0 0
Rax2 SPAC6F6.06c 128 0 0 0 2 2 0 0
CTNS domain 
protein SPAC4C5.03 34 0 0 0 2 2 0 0
Nup120 SPBC3B9.16c 130 0 0 0 2 2 0 0
Asa1 SPAC1006.02 41 0 0 0 2 2 0 0
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Sequence orphan SPAC24C9.04 14 0 0 0 2 2 0 0
Spp2 SPBC17D11.06 53 0 0 0 2 2 0 0
Clr2 SPAC1B3.17 62 0 0 0 2 2 0 0
Tea1 SPCC1223.06 127 0 0 0 2 2 0 0
Sequence orphan SPAC17A2.07c 20 0 0 0 2 2 0 0
Nab2 SPAC14C4.06c 34 0 0 0 2 2 0 0
Conserved protein SPAC6G9.01c 10 0 0 0 2 2 0 0
Ubiquitin-protein 
ligase E3 SPBC16G5.03 31 0 0 0 2 2 0 0




SPAC25H1.06 47 0 0 0 2 2 0 0
SRR1 family protein SPBC14C8.13 29 0 0 0 2 2 0 0
Sgf11 SPAC57A10.14 13 0 0 0 2 2 0 0
Atf31 SPAC22F3.02 24 0 0 0 2 2 0 0
Swd1 SPAC23H3.05c 45 0 0 0 2 2 0 0
Short chain 
dehydrogenase SPAC977.08 26 0 0 0 2 2 0 0
Eng2 SPAC23D3.10c 78 0 0 0 2 2 0 0
Swd1 SPBC354.02c 53 0 0 0 2 2 0 0
Mis16 SPCC1672.10 48 0 0 0 2 2 0 0
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transporter SPCC417.10 57 0 0 0 2 2 0 0
Psy1 SPCC825.03c 33 0 0 0 2 2 0 0
Moc3 SPAC821.07c 55 0 0 0 2 2 0 0
RNA-binding 
protein, G-patch type SPAC2G11.04 33 0 0 0 2 2 0 0
Cwf20 SPCC4B3.14 33 0 0 0 2 2 0 0
Mug117 SPCC645.11c 22 0 0 0 2 2 0 0
DUF1000 family 




SPCC777.17c 12 0 0 0 2 2 0 0
ORMDL family 
protein SPBC119.09c 21 0 0 0 2 2 0 0
Tif212 SPAC32A11.04c 36 0 0 0 2 2 0 0
Mdm10 SPAC17H9.17c 42 0 0 0 2 2 0 0
tRNA specific 
adenosine deaminase SPBC16A3.06 44 0 0 0 2 2 0 0
Hem2 SPAC1805.06c 36 0 0 0 2 2 0 0
Imidazoleglycerol-






SPAC22A12.10 44 0 0 0 2 2 0 0
Metal dependent 
phosphohydrolase SPCC4G3.17 23 0 0 0 2 2 0 0
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Gpi12 SPAPB2B4.01c 28 0 0 0 2 2 0 0
tspO homolog SPBC725.10 18 0 0 0 2 2 0 0
Btn1 SPAC607.09c 44 0 0 0 2 2 0 0




SPCC74.04 60 0 0 0 2 2 0 0
Rng3 SPCC613.04c 84 0 0 2 4 2 0 0
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